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A B S T R A C T
Background
Preterm birth (PTB) is a major factor contributing to global rates of neonatal death and to longer-term health problems for surviving infants.
Both the World Health Organization and the United Nations consider prevention of PTB as central to improving health care for pregnant
women and newborn babies. Current preventative clinical strategies show varied efficacy in different populations of pregnant women,
frustrating women and health providers alike, while researchers call for better understanding of the underlying mechanisms that lead to
PTB.
Objectives
We aimed to summarise all evidence for interventions relevant to the prevention of PTB as reported in Cochrane systematic reviews (SRs).
We intended to highlight promising interventions and to identify SRs in need of an update.
Methods
We searched the Cochrane Database of Systematic Reviews (2 November 2017) with key words to capture any Cochrane SR that prespec-
ified or reported a PTB outcome. Inclusion criteria focused on pregnant women without signs of preterm labour or ruptured amniotic
membranes. We included reviews of interventions for pregnant women irrespective of their risk status. We followed standard Cochrane
methods.
We applied GRADE criteria to evaluate the quality of SR evidence. We assigned graphic icons to classify the effectiveness of interventions as:
clear evidence of benefit; clear evidence of harm; clear evidence of no effect or equivalence; possible benefit; possible harm; or unknown
benefit or harm. We defined clear evidence of benefit and clear evidence of harm to be GRADE moderate- or high-quality evidence with a
confidence interval (CI) that does not cross the line of no effect. Clear evidence of no effect or equivalence is GRADE moderate- or high-
quality evidence with a narrow CI crossing the line of no effect. Possible benefit and possible harm refer to GRADE low-quality evidence
with a clear effect (CI does not cross the line of no effect) or GRADE moderate- or high-quality evidence with a wide CI. Unknown harm or
benefit refers to GRADE low- or very low-quality evidence with a wide CI.
Main results
We included 83 SRs; 70 had outcome data. Below we highlight key results from a subset of 36 SRs of interventions intended to prevent PTB.
Outcome: preterm birth
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Clear evidence of benefit
Four SRs reported clear evidence of benefit to prevent specific populations of pregnant women from giving birth early, including mid-
wife-led continuity models of care versus other models of care for all women; screening for lower genital tract infections for pregnant
women less than 37 weeks' gestation and without signs of labour, bleeding or infection; and zinc supplementation for pregnant women
without systemic illness. Cervical cerclage showed clear benefit for women with singleton pregnancy and high risk of PTB only.
Clear evidence of harm
No included SR reported clear evidence of harm.
No effect or equivalence
For pregnant women at high risk of PTB, bedrest for women with singleton pregnancy and antibiotic prophylaxis during the second and
third trimester were of no effect or equivalent to a comparator.
Possible benefit
Four SRs found possible benefit in: group antenatal care for all pregnant women; antibiotics for pregnant women with asymptomatic
bacteriuria; pharmacological interventions for smoking cessation for pregnant women who smoke; and vitamin D supplements alone for
women without pre-existing conditions such as diabetes.
Possible harm
One SR reported possible harm (increased risk of PTB) with intramuscular progesterone, but this finding is only relevant to women with
multiple pregnancy and high risk of PTB. Another review found possible harm with vitamin D, calcium and other minerals for pregnant
women without pre-existing conditions.
Outcome: perinatal death
Clear evidence of benefit
Two SRs reported clear evidence of benefit to reduce pregnant women's risk of perinatal death: midwife-led continuity models of care for
all pregnant women; and fetal and umbilical Doppler for high-risk pregnant women.
Clear evidence of harm
No included SR reported clear evidence of harm.
No effect or equivalence
For pregnant women at high risk of PTB, antibiotic prophylaxis during the second and third trimester was of no effect or equivalent to a
comparator.
Possible benefit
One SR reported possible benefit with cervical cerclage for women with singleton pregnancy and high risk of PTB.
Possible harm
One SR reported possible harm associated with a reduced schedule of antenatal visits for pregnant women at low risk of pregnancy com-
plications; importantly, these women already received antenatal care in settings with limited resources.
Outcomes: preterm birth and perinatal death
Unknown benefit or harm
For pregnant women at high risk of PTB for any reason including multiple pregnancy, home uterine monitoring was of unknown benefit
or harm. For pregnant women at high risk due to multiple pregnancy: bedrest, prophylactic oral betamimetics, vaginal progesterone and
cervical cerclage were all of unknown benefit or harm.
Authors' conclusions
Implications for practice
The overview serves as a map and guide to all current evidence relevant to PTB prevention published in the Cochrane Library. Of 70 SRs
with outcome data, we identified 36 reviews of interventions with the aim of preventing PTB. Just four of these SRs had evidence of clear
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benefit to women, with an additional four SRs reporting possible benefit. No SR reported clear harm, which is an important finding for
women and health providers alike.
The overview summarises no evidence for the clinically important interventions of cervical pessary, cervical length assessment and vaginal
progesterone because these Cochrane Reviews were not current. These are active areas for PTB research.
The graphic icons we assigned to SR effect estimates do not constitute clinical guidance or an endorsement of specific interventions for
pregnant women. It remains critical for pregnant women and their healthcare providers to carefully consider whether specific strategies
to prevent PTB will be of benefit for individual women, or for specific populations of women.
Implications for research
Formal consensus work is needed to establish standard language for overviews of reviews and to define the limits of their interpretation.
Clinicians, researchers and funders must address the lack of evidence for interventions relevant to women at high risk of PTB due to mul-
tiple pregnancy.
P L A I N   L A N G U A G E   S U M M A R Y
Ways to help pregnant women avoid preterm birth
What is the issue?
Preterm birth, or being born before 37 weeks of pregnancy, is a major reason why newborns die and may also mean long-term disability
for surviving infants. There are many ways healthcare providers try to prevent women from having their babies too early. Pregnant women
may be encouraged to take vitamins, reduce smoking, take medicines for infections or attend regular healthcare visits. Our overview looks
at different ways (or interventions) to prevent preterm birth. We searched for relevant papers in the Cochrane Library on 2 November, 2017.
Why is this important?
Preterm birth is devastating and costly for women, families and health systems. We aimed to summarise relevant information for pregnant
women, healthcare workers and researchers.
What evidence did we find?
We included 83 systematic reviews with evidence about whether or not the intervention was able to reduce pregnant women's chance of
having a preterm birth or a baby death. Seventy of these reviews had information about preterm birth. We categorised the evidence we
found as: clear benefit or harm; no effect; possible benefit or harm; or unknown effect.
Outcome: preterm birth
Clear benefit
We were confident that the following interventions were able to help specific populations of pregnant women avoid giving birth early:
midwife-led continuity models of care versus other models of care for all women; screening for lower genital tract infections; and zinc
supplementation for pregnant women without systemic illness. Cervical stitch (cerclage) was of benefit only for women at high risk of
preterm birth and with singleton pregnancy.
Clear harm
We found no treatment that increased women’s chance of giving birth preterm.
Possible benefit
The following interventions may have helped some groups of pregnant women avoid preterm birth, but we have less confidence in these
results: group antenatal care for all pregnant women; antibiotics for pregnant women with asymptomatic bacteriuria; pharmacological
interventions for smoking cessation; and vitamin D supplements alone for women without health problems.
Possible harm
We found two interventions that may have made things worse for some pregnant women: intramuscular progesterone for women at high
risk of preterm birth with multiple pregnancy; and taking vitamin D supplements, calcium and other minerals for pregnant women without
health problems.
Outcome: perinatal death
Clear benefit
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We were confident in evidence for midwife-led continuity models of care for all pregnant women; and for fetal and umbilical Doppler for
high-risk pregnant women; these interventions appeared to reduce women's chance of experiencing baby death.
Clear harm
We found no intervention that increased women’s risk of baby death.
Possible benefit
We found a possible benefit with cervical stitch (cerclage) for women with singleton pregnancy and high risk of preterm birth.
Possible harm
One review reported possible harm associated with having fewer antenatal visits, even for pregnant women at low risk of pregnancy
problems. The pregnant women in this review already received limited antenatal care.
Outcomes: preterm birth and perinatal death
Unknown benefit or harm
For pregnant women at high risk of preterm birth for any reason including multiple pregnancy, home uterine monitoring was of unknown
benefit or harm. For high-risk pregnant women with multiple pregnancy: bedrest, prophylactic oral betamimetics, vaginal progesterone
and cervical cerclage were all of unknown benefit or harm.
What does this mean?
There is valuable information in the Cochrane Library relevant to women, doctors, midwives and researchers interested in preventing early
birth. We have summarised the results of systematic reviews to describe how well different strategies work to prevent early birth and baby
death. We organised our information in clear figures with graphic icons to represent how confident we were in the results and to point
readers toward promising treatments for specific groups of pregnant women.
Our overview found no up-to-date information in the Cochrane Library for the important treatments of cervical pessary, vaginal proges-
terone or cervical assessment with ultrasound. We found no high-quality evidence relevant to women at high risk of preterm birth due
to multiple pregnancy. It remains important for pregnant women and their healthcare providers to carefully consider whether specific
strategies to prevent preterm birth will be of benefit for individual women, or for specific populations of women.
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B A C K G R O U N D
Preterm birth (PTB) places a substantial burden on economies,
health systems and families worldwide. PTB contributes dispropor-
tionately to global rates of neonatal death, and infants who survive
early birth may suffer serious complications and long-term disabil-
ity (Blencowe 2013; Liu 2015). PTB cost the UK economy £2.9 billion
in a single year (Mangham 2009), while affected families suffered
equally profound financial, social and psychological consequences
(Carson 2015; Hodek 2011; Vigod 2010).
The World Health Organization (WHO) identified PTB as a "top ten"
research priority to 2025 (Yoshida 2016). The United Nations has al-
so positioned PTB research as central to achieving a reduction in
newborn deaths and the Sustainable Development Goals to 2030
(Lawn 2016). Though the PTB rate in countries such as the USA has
fallen, early birth contributes to high mortality in low- and mid-
dle-income countries (Blencowe 2012; Gyamfi-Bannerman 2014).
The March of Dimes and the International Federation of Gynecolo-
gy and Obstetrics Working Group urge researchers to think beyond
current clinical and preventive strategies and to expand basic re-
search to develop new interventions for PTB (Ferrero 2016; Martin
2017).
Description of the condition
PTB is usually defined as birth before 37 weeks + 0 days' gesta-
tion (or 259 days) (Anonymous 1977). The Global Alliance to Pre-
vent Prematurity and Stillbirth (GAPPS) defined 'provider-initiated'
PTB as early births related to: severe maternal, fetal or placental
conditions, maternal request, breech presentation, cephalopelvic
disproportion, or previous caesarean section. In contrast, 'spon-
taneous' preterm births (sPTB) were not related to severe clinical
conditions (Villar 2012). When applied to 60,000+ births, the GAP-
PS classification system found 22% of all early births to occur spon-
taneously and without association to any severe condition (Barros
2015).
This overview is concerned with sPTB rather than provider-initiated
PTB, but in practice the early births reported in included SRs may be
a mix of the two. The United States Vital Statistics and the Office of
National Statistics in the UK do not distinguish spontaneous from
provider-initiated PTB when reporting national rates. A recent US
study makes the distinction, but the PTB Core Outcome Set does
not (Gyamfi-Bannerman 2014; van't HooR 2016).
Description of the interventions
Many interventions to prevent PTB target all pregnant women;
these may begin before or during pregnancy, such as folate supple-
mentation or improved access to antenatal care (Iams 2008). Other
interventions target specific populations of pregnant women con-
sidered to be at higher risk of PTB, such as women with multiple
pregnancy or women who smoke. This overview will include all in-
terventions that could be applied during pregnancy to prevent PTB,
regardless of women's risk factors. In this overview, we included in-
terventions for women with co-morbid conditions such as diabetes
or hypertension, for women with recognised risk factors such as
short cervix or multiple pregnancy, and for pregnant women with-
out any known risk.
How the intervention might work
We do not fully understand the pathways leading to PTB, which lim-
its implementation of appropriate clinical and public health pre-
vention strategies. Interventions may reduce PTB via diverse path-
ways. Nutritional supplements may modify low body mass index
(BMI) to reduce risk, while screening for asymptomatic bacteriuria
may reduce the risk of infection-related PTB. We included SRs of in-
terventions regardless of whether the mechanism of action on PTB
was known.
Why it is important to do this overview
We aim to improve the care of pregnant women. There is a wealth
of information in the Cochrane Library relevant to PTB preven-
tion. Initial searches returned over 800 SRs, and yet there is no
efficient way for researchers, funding organisations, clinicians or
pregnant women themselves to quickly access this evidence. This
overview extends previous efforts to catalogue SRs of PTB interven-
tions (Iams 2008; Piso 2014) and applies the agreed core outcome
set for PTB (van't HooR 2016).
O B J E C T I V E S
We aimed to summarise all evidence for interventions relevant
to the prevention of PTB as reported in Cochrane systematic re-
views (SRs). We intended to highlight promising interventions and
to identify SRs in need of an update.
M E T H O D S
Criteria for considering reviews for inclusion
We applied the inclusion and exclusion criteria below when assess-
ing SRs for this overview.
 
Eligibility Inclusion Exclusion
Participant
level
Population Pregnant women including those with risk factors or
co-morbidities
Pregnant women with singleton or multiple pregnan-
cy
Healthcare providers
Pregnant women with acute signs of
preterm labour
Pregnant women with a previous episode
of preterm labour in current pregnancy
Pregnant women with preterm prelabour
ruptured membranes (PPROM)
Pregnant women with major fetal anom-
alies
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Pregnant women undergoing induction of
labour
Review level Review Cochrane systematic reviews published from 2014 We listed reviews with a relevant popu-
lation and intervention published before
2014 or with a search date prior to 2014
  Trial design Randomised clinical trials (including cluster- or qua-
si-randomised trials)
Any setting, language or year
Non-randomised study designs
  Intervention Behavioural, clinical or health systems interventions Interventions for preconception only
Interventions to prevent or treat miscar-
riage
Interventions comprising fertility treat-
ment
  Comparison One main comparison (designated as such by review
authors)
Alternative intervention or no intervention (including
placebo)
Additional review comparisons do not con-
tribute to data summaries
  Outcome Preterm birth outcome (any gestational age (GA) val-
ue) specified or reported (prespecified or post-hoc)
Preterm birth outcome (any GA value) not
specified or reported
 
The inclusion and exclusion criteria define a pregnant population
without signs of preterm labour. We excluded SRs of interventions
for women with PPROM because these women receive individu-
alised management with interventions with a short timeframe to
delivery and, often, the goal of improving neonatal outcomes (e.g.
magnesium sulphate for neuro protection). We excluded reviews of
interventions targeting the neonate.
Search methods for identification of reviews
Only Cochrane systematic reviews were eligible for inclusion in this
overview. We searched the Cochrane Database of Systematic Re-
views (2 November 2017) with a broad strategy using all possible
keywords to capture reviews relevant to preterm birth (see Appen-
dix 1).
Data collection and analysis
We followed standard methods for overviews of reviews as de-
scribed below.
Selection of reviews
We conducted eligibility in duplicate with all conflicts resolved
through discussion with a third overview author.
We staged eligibility assessment. First, two overview authors as-
sessed titles and abstracts to ensure that SRs targeted appropri-
ate populations of pregnant women and summarised relevant in-
terventions. Second, we set aside all relevant Cochrane protocols;
we will check the status of these in future updates of this overview.
We set aside potentially relevant titles published before 2014. Final-
ly, we assessed the full text of remaining reviews to explore further
whether the population and intervention met our inclusion criteria
and to confirm that the review included randomised trial evidence.
We list characteristics of reviews excluded at full-text assessment.
Data extraction and management
For each included SR one overview author (NM) independently ex-
tracted data; a second overview author checked the data for accu-
racy. We resolved disagreements by discussion. We extracted the
following characteristics from each included SR.
1. Search date
2. Number of trials included in the review
3. Number of participants included in the review
4. Overview outcomes with data
5. Authors' conclusions
Two overview authors piloted the data synthesis tables to improve
the content and presentation of SR results. When the final format
was agreed amongst all overview authors, one overview author cre-
ated figures to present outcome data and a second overview author
checked the figures.
Assessment of methodological quality of included reviews
Methodological quality of included systematic reviews
Several recent publications have explored problems with the AMS-
TAR tool for assessing systematic review (SR) quality (Burda 2016;
Faggion 2015; Pollock 2017; Shea 2007; Wegewitz 2016). Because of
the identified shortcomings of AMSTAR, we decided against using it
and explored using the Risk of Bias in Systematic Reviews (ROBIS)
quality checklist instead.
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ROBIS users first establish the relevance of the systematic review
(SR) by checking that the population, intervention, comparator
and outcomes align between the review and overview. Next, re-
searchers use ROBIS to consider review methods: study eligibility
criteria; identification and selection of studies; data collection and
study appraisal; and synthesis and findings. Key questions within
each of these four domains sum to an overall risk of bias for the re-
view. Throughout, the tool prompts assessors to flag specific con-
cerns. Finally, ROBIS requires the assessors to weigh their concerns
with SR methods alongside SR conclusions for a judgement of low,
high or unclear risk of bias (Whiting 2016).
Quality of trial evidence included in reviews
We did not reassess the risks of bias for the individual trials includ-
ed in eligible SRs. 'Risk of bias' assessment is a component of all
Cochrane Reviews; review authors consider aspects of trial conduct
and reporting and note whether bias may have impacted the trial's
reported effect estimates (Higgins 2011a). Further, when we eval-
uated pooled outcome data from a particular SR, we made use of
the review authors’ GRADE assessments. GRADE incorporates the
review authors' 'Risk of bias' judgements for individual trials com-
prising pooled estimates. Where review authors did not undertake
GRADE, we ourselves reviewed pooled summary statistics and tri-
als' risks of bias according to criteria described in the GRADE Hand-
book (Schünemann 2013).
Data synthesis
Types of outcomes
We included Cochrane systematic reviews that specified or re-
ported preterm birth (PTB) as one of the outcome measures. We
planned to include all core outcome set domains for effective-
ness, safety, maternal satisfaction and economic costs (van't HooR
2016). Due to variation in outcome definition and reporting, and
to the large number of included SRs, we present outcome data for
PTB (any gestational age (GA) value) and perinatal death (PD), on-
ly (PD includes stillbirth and neonatal death). Formal consensus
work with diverse stakeholders (including parents, midwives and
other health professionals) confirmed GA at delivery and offspring
mortality as the top two clinical outcomes for evaluating interven-
tions to prevent preterm birth (van't HooR 2016). Updates of this
overview will explore adding additional outcome domains and/
or specific outcome measures. As stated above, we expect most
SR reporting of PTB outcomes may include both spontaneous and
provider-initiated early births.
Data synthesis and presentation
We planned to structure data synthesis as in other Cochrane
overviews (Farquhar 2018; Jones 2012; Lassi 2015; Welsh 2015). Due
to the large number of included SRs, we instead created figures to
present review data visually. We assigned graphic icons to commu-
nicate the direction of review effect estimates and our confidence
in the available data. The graphic icons indicate mutually exclusive
assessment categories: clear evidence of benefit; clear evidence of
harm; clear evidence of no effect or equivalence; possible benefit;
possible harm; or unknown benefit or harm. Our presentation of
data is modelled on graphics produced by the WHO to describe dif-
ferent types of workers and their roles in maternal and newborn
care (http://optimizemnh.org/optimizing-health-worker-roles-ma-
ternal-newborn-health/).
We separated SRs of interventions to prevent PTB from SRs of inter-
ventions targeting other problems during pregnancy. We then or-
ganised SR outcome data in figures according to type of interven-
tion: device, health systems, lifestyle, medicines, multiple interven-
tions, nutrition, screening, psychosocial, and surgical. The catego-
ry of 'multiple' interventions includes SRs where different types of
interventions were tested for a particular problem; for example, the
SR of interventions to prevent nausea in pregnancy included both
drug and acupressure interventions.
To assign a graphic icon we first considered the pooled summary
statistic and confidence interval, any GRADE judgements made by
the review author team and the amount of information present:-
the number of trials, women and events contributing to the meta-
analysis. GRADE criteria include: study design limitations in trials
contributing data; imprecision of effects (wide confidence inter-
vals, sparse data or both); inconsistency (unexplained heterogene-
ity as measured by the I2 statistic); indirectness (when trials test a
different population, intervention, comparison or outcome than is
specified in the review); and publication bias. All randomised trial
evidence begins as of high certainty but may be downgraded by one
for a ‘serious’ problem or by two for 'very serious' problem with any
of these criteria. The GRADEpro Guideline Development Tool sums
downgrading decisions into a quality rating of high, moderate, low,
or very low (Schünemann 2013).
There is a large literature on conducting, interpreting and com-
municating GRADE assessment (Guyatt 2011a; Santesso 2015a;
Santesso 2015b). Researchers continue to explore ways to ex-
press SR effect estimates and to delineate the scope of their inter-
pretation (Hultcrantz 2017). Our graphic icons communicate the
GRADE quality assessment found in SR 'Summary of findings' ta-
bles. Where SR authors did not GRADE relevant trial evidence for
PTB or PD, two overview authors independently applied GRADE
criteria and resolved disagreement through discussion (GRADE as-
sessments not shown).
For all included SRs, two overview authors independently assessed
data for the outcomes of PD and PTB to assign a graphic icon. We
resolved disagreements through discussion or by consultation with
a third overview author.
Limitations of the overview and bias in the review process
One limitation of our overview is its restriction to Cochrane system-
atic reviews. Including all relevant, published SRs may have cap-
tured more current evidence on important topics. Cochrane Re-
views are also all published in the English language. Finally, our
search strategy did not include unpublished, industry and govern-
mental SRs.
To minimise bias in the overview process, we followed standard re-
view methods including duplication of effort. Where an overview
author was also an author of a relevant SR, they were excluded from
eligibility assessment and data synthesis for that SR.
R E S U L T S
Search results
We searched the Cochrane Database of Systematic Reviews (2 No-
vember 2017) with a list of key words to capture all systematic re-
views (SRs) specifying or reporting any preterm birth (PTB) out-
come (See Appendix 1 for the search strategy). We documented as-
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sessment of titles and full-text reviews in a study flow diagram (See
Figure 1). We used Covidence software to manage eligibility assess-
ment for 898 titles. Two overview authors independently assessed
titles and full texts against prespecified inclusion and exclusion cri-
teria. We resolved discrepancies between overview authors by dis-
cussion with a third author. No overview author assessed his or her
own SR (several eligible reviews were authored by members of the
overview team).
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Figure 1.   Study flow diagram. Search date 2 November 2017
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Figure 1.   (Continued)
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We included 83 SRs; their characteristics appear in Table 1; 70 in-
cluded reviews reported relevant outcome data. We documented
reasons for exclusion of 24 reviews at full-text assessment in Table
2. We identified 33 protocols for SRs potentially relevant to future
versions of this overview; these titles will be assessed for future ver-
sions of the overview.
Out-of-date systematic reviews
Our protocol stated that we would apply a decision tree to poten-
tially eligible but out-of-date reviews - SRs published before 2014
or with a search date before 2014. We found 96 reviews in this cat-
egory. It was not feasible to conduct new searches for all of these
reviews. Some reviews in this category are currently in the editorial
process, while other reviews may summarise evidence for interven-
tions no longer in use. We regret that we were unable to complete
further assessment of these SR titles. As one peer reviewer pointed
out - there may be interventions associated with harm in the list of
out-of-date reviews, because authors would be less likely to com-
plete new trials or to update reviews of interventions where there
was known evidence of harm. We listed the titles in Appendix 2.
Description of included reviews
We documented key characteristics of 83 included studies in Table
1, including the search date, number of trials, number of women
and the authors' conclusions about the effectiveness of the inter-
ventions. The language of authors' conclusions is directly quoted
from the original Cochrane published reviews. Of 83 included SRs,
seven had no randomised trials (i.e. these are 'empty reviews'). Six
further SRs reported no trial data for either overview outcome of
PTB or perinatal death (PD). All remaining 70 SRs contributed effect
estimates for at least one overview outcome.
Methodological quality of included reviews
As noted above, researchers identified problems with the AMSTAR
tool to assess SR quality (Burda 2016; Pollock 2017). We decid-
ed not to use AMSTAR and explored using the ROBIS tool instead.
We decided against using ROBIS as well, because all SRs includ-
ed in this overview followed standard methodology recommended
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011b). For more recent SR updates, review authors also
followed methods set out by the Cochrane Editorial Unit (i.e. MECIR
standards Higgins 2016). We are confident that all included SRs are
of low risk of methods bias.
EFect of interventions
Notes for Interpreting Graphic Icons
Graphic Icons
We summarised systematic review (SR) evidence for the outcomes
of PTB and PD by assigning one of six graphic icons to indicate our
confidence in and interpretation of the available evidence. Figure
2 shows the icons and explains the mutually exclusive assessment
categories. The first three categories represent GRADE moderate-
or high-quality evidence for which we found either clear benefit,
clear harm or clear evidence of no effect (i.e. equivalence with a
comparator). These categories are identified by a green tick, a red-
cross and a green equal-sign icon, respectively. For 'clear' benefit
or harm, the confidence interval associated with the effect size did
not cross the line of no effect. For 'clear evidence of no effect or
equivalence' we considered a confidence interval within the range
of risk ratio (RR) 0.75 to 1.25 as sufficiently narrow to indicate a min-
imal effect relative to the comparator; these are thresholds recom-
mended by GRADE (Guyatt 2011b). The overview author team indi-
vidually discussed the handful of cases where an SR reported the
odds ratio rather than relative risk.
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Figure 2.   All icons by Freepik at www.flaticon.com.
 
Continuing down Figure 2, two yellow icons represent evidence for
which we had less confidence due to risks of bias in trials, impre-
cision or other GRADE criteria for downgrading evidence quality
(Schünemann 2013). The yellow icons indicate possible benefit (the
plus sign) or possible harm (the minus sign). Yellow icons represent
GRADE moderate- or high-quality evidence when the confidence
interval crossed the line of no effect. Yellow icons also represent
GRADE low-quality evidence when the finding was of clear bene-
fit or harm (i.e. the confidence interval did not cross RR 1.0). We
must emphasise the reduced confidence and caution we intended
to communicate when assigning the yellow graphic icons.
Finally, we assigned a blue question mark icon to indicate 'un-
known harm or benefit' associated with the relative effect of an in-
tervention versus a comparator. The blue question-mark icon indi-
cates GRADE low-quality evidence with a confidence interval cross-
ing the line of no effect as well as all GRADE very low-quality evi-
dence.
Evidence 'Quality' or 'Certainty'?
Our categories of assessment follow GRADE ratings of high, mod-
erate, low or very low to indicate the quality of evidence rather
than its certainty. Though evidence quality and certainty are of-
ten used interchangeably, 'certainty' represents newer language
that extends GRADE methods to the development of formal clini-
cal guidance (Hultcrantz 2017). This overview does not constitute
formal clinical guidance. The SR evidence summarised here would
be considered "non-contextualised" rather than "contextualised"
in the newer GRADE framework that aims to situate evidence in clin-
ical, economic and geographic contexts.
SRs included in this overview applied GRADE criteria to a single out-
come independently rather than to a set of critical outcomes val-
ued together, as guideline developers might. SRs did not pre-spec-
ify thresholds for interpreting effect size or confidence intervals,
and, though most SRs identified trial countries in their 'Summary
of findings' tables, none reported this geographic information per
outcome. No SR calculated a minimum information size required
for meta-analysis. Most SRs did not incorporate formal analyses of
the economic cost or of the acceptability of interventions to preg-
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nant women. Finally, included Cochrane SRs do not make clinical
recommendations (see Higgins 2011b, section 12.7.4 "Common er-
rors in reaching conclusions").
Therefore, a GRADE of moderate or high quality in this overview
reflects our confidence that the pooled estimate is correct (i.e. its
'quality') rather than an endorsement of the intervention's use in a
specific clinical setting or population of pregnant women. Follow-
ing this, the overview graphic icons do not represent clinical rec-
ommendations for the use of interventions. The graphic icons rep-
resent the quality of the evidence found in reviews and direct read-
ers to the full text of SRs for further scrutiny.
Presentation of results
Due to the large number of reviews we wanted to included in this
overview, and because we wanted to avoid presenting 50 pages of
data tables, we took decisions to limit the information presented in
tables and figures. Figures 3 to 19 summarise evidence from the 83
included reviews.
We grouped SRs specifically targeting preterm birth prevention
(Figures 3 to 10) and SRs targeting either diabetes or other prob-
lems women might face during pregnancy (Figures 11 to 19). Inter-
ventions targeting PTB had this indication stated in the SR title or
had PTB as a primary review outcome. We also grouped SRs ac-
cording to intervention type: device, health systems, lifestyle, med-
icines, multiple interventions, nutrition, screening, psychosocial,
and surgical. In all figures below 'Not reported' means that no trial
included in the SR reported data for that particular outcome. 'Not
a review outcome' means that the SR did not search eligible trials
for that outcome because the outcome was not a review priority.
Finally, 'No trials' indicates an empty SR.
Results from all SRs
We included 83 SRs; seven of these were empty reviews (i.e. includ-
ed no randomised trials), and a further six SRs had no trial data
for either of the overview outcomes of PD or PTB. We categorised
available outcome effect estimates as of clear benefit, clear harm,
clear evidence of no effect or equivalence, possible benefit, possi-
ble harm or unknown benefit or harm as explained in Figure 2.
The figures of graphic icons are not intended to replace close in-
spection of individual SRs and the often complicated results found
there. Rather, our overview intends to assess the quality of evi-
dence for the key outcomes of preterm birth and perinatal death
and to signpost readers interested in specific effect estimates to
full SRs. Individual SRs report complete details of the relevant clin-
ical populations and geographic settings, trials' risks of bias, and
forest plots indicating the relative contribution of individual trials
to a pooled estimate. The Characteristics of included studies table
(Table 1) may be read in tandem with the figures of graphic icons;
this table includes information on the review search date, the num-
ber of clinical trials and pregnant women included in the review,
overview outcome measures reported and review authors' conclu-
sions.
Not all included SRs reported on both overview outcomes of
preterm birth and perinatal death. For some SRs, our figures sum-
marise effect estimates for more than one comparison. No SR re-
ported spontaneous PTB as distinct from PTB, and we expect most
results below represent a mix of spontaneous and provider-initiat-
ed PTB.
We report results for preterm birth and perinatal death separate-
ly. For preterm birth, we summarised any outcome measure of
preterm birth (any gestational age (GA) value) and followed individ-
ual SR decisions to prioritise specific time points (e.g. if we found
PTB < 34 weeks' gestation in the 'Summary of findings' table and
other time points in the text, we took the measure used in the 'Sum-
mary of findings' table). We note that perinatal death as reported
in SRs refers to stillbirths and neonatal deaths counted together.
Results from reviews of interventions targeting PTB prevention
Thirty-six SRs summarised evidence for interventions with the aim
of preterm birth prevention. The following figures present graph-
ic icons assigned to SR evidence for the outcomes of preterm birth
and perinatal death: Figure 3 Device; Figure 4 Health systems; Fig-
ure 5 Lifestyle; Figure 6 Medicines; Figure 7 Nutrition; Figure 8
Psychosocial; Figure 9 Screening; and Figure 10 Surgical. Because
these interventions were intended as preterm birth prevention, we
include details of any preterm birth-related risk factors in the target
populations.
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Systematic reviews with no included trials
The following SRs targeted preterm birth prevention but included
no randomised clinical trials: nutritional advice in multiple preg-
nancy (Bricker 2015b); risk-scoring systems for predicting preterm
birth (Davey 2015); screening for genital Chlamydia (Low 2016); and
reduction in the number of fetuses in multiple pregnancy (Dodd
2015a).
Impact on preterm birth rates
Clear evidence of preterm birth reduction
Clear evidence of benefit signals evidence of GRADE moderate or
high quality with a confidence interval that does not cross the line
of no effect. We found four SRs reporting clear evidence of benefit to
prevent specific populations of pregnant women from giving birth
early. These reviews were: midwife-led continuity models of care
versus other models of care for all women (Sandall 2016); cervical
cerclage for women at high risk of preterm birth and with single-
ton pregnancy (Alfirevic 2017a); zinc supplementation for pregnant
women without systemic illness (Ota 2015a); and antenatal lower
genital tract infection screening for pregnant women less than 37
weeks' gestation and without signs of labour, bleeding or infection
(Sangkomkamhang 2015).
Clear evidence of harm
Clear evidence of harm refers to evidence of GRADE moderate or
high quality with a confidence interval that does not cross the line
of no effect. No included SR reported clear evidence of harm asso-
ciated with an intervention; that is, we found no intervention that
increased women’s chances of giving birth preterm.
Clear evidence of no eFect or equivalence
The following SRs reported evidence of GRADE moderate or high
quality with a narrow confidence interval crossing the line of no ef-
fect. These interventions we categorised to be of clear evidence of
no effect or equivalence with a comparator: alternative versus stan-
dard packages of antenatal care for women at low risk of develop-
ing pregnancy complications (Dowswell 2015); bed rest for women
with high risk of preterm birth and singleton pregnancy (Sosa 2015);
antibiotic prophylaxis during the second and third trimester for all
women or for women with high risk of PTB (Thinkhamrop 2015);
calcium supplementation (other than for hypertension) for all preg-
nant women (Buppasiri 2015); daily oral iron supplementation for
all pregnant women (Peña-Rosas 2015a); vitamin C supplementa-
tion for all pregnant women (Rumbold 2015a); vitamin E supple-
mentation for all pregnant women (Rumbold 2015b); routine ultra-
sound in later pregnancy for women in unselected or low-risk pop-
ulations (Bricker 2015a); and screening and subsequent manage-
ment for thyroid dysfunction for women before or during pregnan-
cy without pre-existing thyroid problems (Spencer 2015).
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Possible benefit
Possible benefit refers to GRADE low-quality evidence with clear
benefit (the confidence interval does not cross the line of no effect)
or GRADE moderate- or high-quality evidence with wide confidence
intervals crossing the line of no effect. We found evidence of pos-
sible benefit to specific populations of women reported in the fol-
lowing SRs: group antenatal care for all pregnant women (Catling
2015); antibiotics for pregnant women with asymptomatic bacteri-
uria (Smaill 2015); pharmacological interventions for smoking ces-
sation for pregnant women who smoke (Coleman 2015); and vita-
min D supplements alone for women without pre-existing condi-
tions such as diabetes (De-Regil 2016).
Possible harm
Possible harm refers to GRADE low-quality evidence with clear
harm (the confidence interval does not cross the line of no effect)
or GRADE moderate- or high-quality evidence with wide confidence
intervals crossing the line of no effect. One SR reported possible
harm for the effects of intramuscular progesterone for women at
high risk of preterm birth with multiple pregnancy (Dodd 2017). An-
other review found possible harm with vitamin D supplements, cal-
cium and other minerals for pregnant women without pre-existing
conditions (De-Regil 2016).
Unknown harm or benefit
Ten SRs reported evidence for the outcome of PTB that we cat-
egorised to be of unknown harm or benefit due to effect esti-
mates with wide confidence intervals and evidence of GRADE low
or very low quality: home uterine monitoring for high-risk preg-
nant women (Urquhart 2017); bed rest for women with multiple
pregnancy (da Silva Lopes 2017); restricted caffeine intake for all
women (Jahanfar 2015); duration of treatment for women with
asymptomatic bacteriuria (Widmer 2015); treating genital Chlamy-
dia trachomatis infection in pregnancy (Cluver 2017); vaginal prog-
esterone for women with multiple pregnancy (Dodd 2017); prophy-
lactic oral betamimetics for women with multiple pregnancy (Ya-
masmit 2015); intermittent oral iron supplementation for women
without tuberculosis or HIV (Peña-Rosas 2015a); iodine supplemen-
tation for pregnant women without thyroid disorders, tuberculosis
or HIV (Harding 2017); and multiple micronutrient supplements for
pregnant women without HIV (Haider 2017).
Systematic reviews not reporting data for a preterm birth outcome
The following SRs included trials that did not report data for
any preterm birth outcome measure: increasing prenatal care
use (Till 2015); specialised antenatal clinics for multiple pregnan-
cy (Dodd 2015b); and pyridoxine (vitamin B6) supplementation
(Salam 2015c).
Impact on perinatal death in preterm birth prevention reviews
Clear evidence of reduction in perinatal deaths
Two SRs reported evidence of GRADE moderate or high quality with
clear evidence of benefit (the confidence interval does not cross
the line of no effect): midwife-led continuity models of care for all
pregnant women (Sandall 2016); and fetal and umbilical Doppler
for pregnant women at high risk (Alfirevic 2017b).
Clear evidence of harm
No SR reported clear evidence of harm associated with the inter-
vention; no intervention summarised here increased a woman’s
chance of PD.
Clear evidence of no eFect or equivalence
The following SRs reported GRADE moderate- or high-quality ev-
idence with narrow confidence intervals crossing the line of no
effect, suggesting the intervention had no effect or equivalence
to a comparator: antibiotic prophylaxis during the second and
third trimester for all pregnant women and women at high risk
of PTB (Thinkhamrop 2015); calcium supplementation (other than
for preventing or treating hypertension) for all pregnant women
(Buppasiri 2015); vitamin C for all pregnant women (Rumbold
2015a); vitamin E supplementation for all pregnant women (Rum-
bold 2015b); routine ultrasound in late pregnancy (after 24 weeks'
gestation) for unselected pregnant women and women of low risk
(Bricker 2015a); and screening and subsequent management for
thyroid dysfunction before or during pregnancy, for women with-
out pre-existing thyroid disorders (Spencer 2015).
Possible benefit
Possible benefit refers to GRADE low-quality evidence with clear
benefit (the confidence interval does not cross the line of no effect)
or GRADE moderate- or high-quality evidence with wide confidence
intervals crossing the line of no effect. One SR reported possible
benefit of cervical stitch (cerclage) for women with singleton preg-
nancy and high risk of preterm birth (Alfirevic 2017a).
Possible harm
Possible harm refers to GRADE low-quality evidence with clear
harm (the confidence interval does not cross the line of no effect)
or GRADE moderate- or high-quality evidence with wide confidence
intervals crossing the line of no effect. One SR reported possible
harm associated with a reduced schedule of antenatal visits for
pregnant women at low risk of pregnancy complications; these
pregnant women already received antenatal care in settings with
limited resources (Dowswell 2015).
Unknown harm or benefit
Evidence summarised in the following SRs was of GRADE low or
very low quality with a wide confidence interval crossing the line of
no effect: home uterine monitoring for high-risk pregnant women
(Urquhart 2017); group versus conventional antenatal care for all
pregnant women (Catling 2015); specialised antenatal clinics for
women with multiple pregnancy (Dodd 2015b); bedrest for women
with multiple pregnancy (da Silva Lopes 2017); treating genital
Chlamydia trachomatis infection in pregnancy (Cluver 2017); intra-
muscular progesterone for women with multiple pregnancy (Dodd
2017); vaginal progesterone for women with multiple pregnancy
(Dodd 2017); prophylactic oral beta mimetics for women with mul-
tiple pregnancy (Yamasmit 2015); daily oral iron supplementation
for all pregnant women (Peña-Rosas 2015a); intermittent oral iron
supplements for women without tuberculosis or HIV (Peña-Rosas
2015b); iodine supplementation for pregnant women without thy-
roid disorders, tuberculosis or HIV (Harding 2017); multiple mi-
cronutrient supplements for pregnant women without HIV (Haider
2017); vitamin D supplementation for pregnant women without
pre-existing conditions such as diabetes (De-Regil 2016); zinc sup-
plementation for pregnant women without systemic illness (Ota
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2015a); Cervical stitch (cerclage) for women with multiple pregnan-
cy (Rafael 2014); and Treating periodontal disease (Iheozor-Ejiofor
2017).
Systematic reviews not reporting data for the outcome perinatal
death
The following SRs included trials that did not report the outcome
of perinatal death: incentives for increasing prenatal care for all
pregnant women (Till 2015); bed rest for women with singleton
pregnancy and high risk of PTB (Sosa 2015); restricted caffeine
for all pregnant women (Jahanfar 2015); antibiotics for asympto-
matic bacteriuria (Smaill 2015); duration of treatment for asympto-
matic bacteriuria (Widmer 2015); and antenatal lower genital tract
infection screening for women without signs of preterm labour
(Sangkomkamhang 2015).
Results from reviews of interventions targeting diabetes or
other problems during pregnancy
Forty-seven SRs summarised relevant evidence for interventions
targeting diabetes or other problems women might face during
pregnancy. All reviews were included in this overview because they
included an eligible population of pregnant women and prespec-
ified or reported data for an overview priority outcome (perina-
tal death or any measure of preterm birth). The following figures
present the graphic icons assigned to SR evidence for these out-
comes: Figure 11 Health systems; Figure 12 Lifestyle; Figure 13 Med-
icines targeting diabetes; Figure 14 Medicines targeting other preg-
nancy conditions; Figure 15 Multiple interventions; Figure 16 Nutri-
tion; Figure 17 Psychosocial; Figure 18 Screening; Figure 19 Surgi-
cal. We found no SRs of Device interventions, so there is no figure
for this category.
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Figure 19.
 
For the sake of brevity, below we do not summarise individual SRs
with evidence of unknown harm or benefit for overview outcomes
as symbolised by the blue question mark graphic - this task would
reiterate what is already apparent in the figures - i.e. there are many
interventions for which we have little trial evidence summarised in
SRs. Neither do we list the SRs that did not report outcome data -
this information may also be found directly in the figures. As above,
we direct readers to consider evidence presented in the figures to-
gether with the 'Characteristics of included systematic reviews' ta-
ble (Figure 1).
Systematic reviews with no included trials
The following SRs targeted diabetes or other problems during preg-
nancy and prespecified an overview priority outcome but included
no randomised clinical trials: customised versus population-based
growth charts as a screening tool for detecting small for gestation-
al age babies (Carberry 2014); routine blood cultures for the man-
agement of pyelonephritis in pregnancy (Gomi 2015); and directed
preconception health programs and interventions for women who
are overweight or obese (Opray 2015).
Impact on preterm birth
Clear evidence of benefit
One SR reported evidence of GRADE moderate or high quality with
clear evidence of benefit (the confidence interval does not cross the
line of no effect): lifestyle interventions for the treatment of women
with gestational diabetes (Brown 2017a).
Clear evidence of harm
No SR reported clear evidence of harm associated with the inter-
vention; no intervention summarised here increased a woman’s
chance of PTB.
Clear evidence of no eFect or equivalence
The following SRs reported GRADE moderate- or high-quality evi-
dence with narrow confidence intervals crossing the line of no ef-
fect, suggesting the intervention had no effect or equivalence to
a comparator: combined health systems interventions to improve
antenatal care uptake (Mbuagbaw 2015); diet or exercise or both for
preventing excessive weight gain in pregnancy (Muktabhant 2015);
vitamin A supplementation (McCauley 2015); antihelminthics dur-
ing pregnancy (Salam 2015a); psychosocial interventions to stop
smoking in pregnancy (Chamberlain 2017); and fetal and umbilical
Doppler ultrasound in normal pregnancy (Alfirevic 2015).
Possible benefit
Possible benefit refers to GRADE low-quality evidence with clear
benefit (the confidence interval does not cross the line of no effect)
or GRADE moderate- or high-quality evidence with wide confidence
intervals crossing the line of no effect. Three SRs reported such
evidence for: diet and exercise interventions for preventing gesta-
tional diabetes mellitus (Bain 2015); antenatal dietary education
and supplementation to increase energy and protein intake (Ota
2015b); and pharmacological interventions for promoting smoking
cessation during pregnancy (Coleman 2015).
Possible harm
Possible harm refers to GRADE low-quality evidence with clear
harm (the confidence interval does not cross the line of no effect)
or GRADE moderate- or high-quality evidence with wide confidence
intervals crossing the line of no effect. One SR reported such evi-
dence for the effects of external cephalic version for breech presen-
tation before term (Hutton 2015).
Unknown harm or benefit
Evidence summarised in many SRs was of GRADE low or very low
quality with a wide confidence interval crossing the line of no effect
(see Figures 11 to 19).
Impact on perinatal death
Clear evidence of benefit
Two SRs reported evidence of GRADE moderate- or high-quality
with clear evidence of benefit (the confidence interval does not
cross the line of no effect): combined health systems interven-
tions to improve antenatal care uptake (Mbuagbaw 2015); and fetal
and umbilical Doppler ultrasound in high-risk pregnancy (Alfirevic
2017b).
Clear evidence of harm
No SR reported clear evidence of harm associated with the inter-
vention; no intervention summarised here increased a woman’s
chance of PD.
Clear evidence of no eFect or equivalence
The following SRs reported GRADE moderate- or high-quality ev-
idence with narrow confidence intervals crossing the line of no
effect, suggesting the intervention had no effect or equivalence
to a comparator: combined health systems interventions to im-
prove antenatal care uptake (Mbuagbaw 2015); vitamin A supple-
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mentation (McCauley 2015); and antihelminthics during pregnancy
(Salam 2015a).
Possible benefit
Possible benefit refers to GRADE low-quality evidence with clear
benefit (the confidence interval does not cross the line of no effect)
or GRADE moderate- or high-quality evidence with wide confidence
intervals crossing the line of no effect. One SR reported such evi-
dence for computerised cardiotocography in the SR Antenatal car-
diotocography for fetal assessment (Grivell 2015).
Possible harm
Possible harm refers to GRADE low-quality evidence with clear
harm (the confidence interval does not cross the line of no effect)
or GRADE moderate- or high-quality evidence with wide confidence
intervals crossing the line of no effect. No SR reported such evi-
dence.
Unknown harm or benefit
Evidence summarised in many SRs was of GRADE low or very low
quality with a wide confidence interval crossing the line of no effect
(see Figures 11 to 19).
Network meta-analysis
We found no eligible Cochrane Reviews with network meta-analy-
ses (NMA) for inclusion in this overview. If in future updates of the
overview we identify relevant reviews, we will apply the method-
ologies outlined in our protocol to pilot GRADE for important net-
work comparisons and outcomes and to present key network re-
sults visually.
Interactive 'Summary of findings' tables
We did not pilot an interactive 'Summary of findings' table for this
version of the overview, but we aim to pilot ideas for presenting lay-
ered data tables in online versions of the overview for the next up-
date.
D I S C U S S I O N
There is little consensus or guidance on the appropriate rationale,
methodology or outputs for overviews of systematic reviews (SRs
(Ballard 2017; Pieper 2012; Pollock 2016). We have summarised the
evidence from relevant Cochrane Reviews using graphic icons to
communicate both our confidence in, and the relative effective-
ness of diverse interventions with possible impact on preterm birth
(PTB). We stress that preterm birth rates reported in included SRs
are likely to be a mix of provider-initiated and spontaneous PTB.
Perinatal deaths include both stillbirth and neonatal deaths.
Summary of main results
We found 36 SRs evaluating interventions with PTB prevention as
the main focus. Most reviews evaluated interventions related to
health systems or screening, or tested the impact of medicines and
vitamin supplements.
Four reviews reported clear evidence of benefit, with three relevant
to a general pregnant population: midwife-led continuity models
of care versus other models of care for all women (Sandall 2016);
zinc supplementation for pregnant women without systemic ill-
ness (Ota 2015a); and antenatal lower genital tract infection screen-
ing for women without signs of preterm labour (Sangkomkamhang
2015). Cervical cerclage was the only surgical intervention found to
be of benefit, and is relevant only for women with high risk of PTB
and singleton pregnancy (Alfirevic 2017a).
It is worth noting that only midwife-led continuity models of care
for all pregnant women (Sandall 2016) showed both reduction in
PTB and improvement in perinatal survival. The review authors
called for further investigation into how a model of care might pre-
vent PTB. They stressed that this is a complex intervention that re-
quires theoretical modelling of the relationships between process-
es and outcomes in the trial. Authors cautioned against general-
ising results to a population with health complications and noted
that no included trial took place in a resource-constrained setting.
Authors of the zinc supplementation review qualified their finding
of benefit to say that most women in included trials were of low
income and may have had poor nutrition (Ota 2015a). Infection
screening programs were relevant to a general population of preg-
nant women (Sangkomkamhang 2015), whilst the benefit of cervi-
cal cerclage was only relevant to women at high risk of PTB and sin-
gleton pregnancy (Alfirevic 2017a).
No included reviews reported clear evidence of harm, which is very
reassuring.
Reviews targeting diabetes or other pregnancy conditions
Forty-seven included reviews described various interventions tar-
geting diabetes and other conditions in pregnancy. Each speci-
fied or reported a PTB outcome, but PTB prevention was not their
primary focus. The review by Brown 2017a reported clear bene-
fit of lifestyle interventions for women with gestational diabetes;
lifestyle interventions usually involved healthy eating, exercise and
self-monitoring of glucose concentrations. Review authors cau-
tioned against generalising this result to women in low- or mid-
dle-income countries.
No review targeting diabetes or other health problems during preg-
nancy reported benefit for both PTB and perinatal death outcomes.
Combined community and health systems interventions to im-
prove antenatal care coverage reduced pregnant women’s chances
of experiencing perinatal death but had no clear impact on PTB
rates (Mbuagbaw 2015). However, this review finding is from a sin-
gle trial investigating augmented care for African-American women
with multiple pregnancy risks (Klerman 2001).
Fetal and umbilical Doppler for high-risk pregnant women also
showed a reduction in perinatal death but no clear impact on PTB
rates (Alfirevic 2017b). As most trials did not have a clearly-defined
management protocol that followed abnormal Doppler test, it is
difficult to be certain which aspect of subsequent care is the most
important – the obvious candidates are better timing of delivery,
more appropriate mode of labour (vaginal versus caesarean), and
better targeting of antenatal corticosteroids.
Reassuringly, no included reviews reported clear evidence of harm.
Overall completeness and applicability of evidence
One of our main aims was to highlight strategies to prevent sponta-
neous preterm birth (sPTB), but none of the included Cochrane Re-
views reported sPTB as an outcome distinct from provider-initiated
PTB. Despite their focus on PTB prevention, none of the 36 relevant
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Cochrane Reviews referenced the Global Alliance to Prevent Pre-
maturity and Stillbirth (GAPPS) classification system for PTB (Villar
2012). We would encourage researchers to try to apply these dis-
tinctions to enable more nuanced analysis of PTB-related interven-
tions.
What is missing from the overview?
We identified 96 SRs that may have been eligible during title assess-
ment but were out-of-date (these are listed in Appendix 2). We re-
gret that we were unable to look further into these SRs.
Our peer reviewers noted that the overview misses out three wide-
ly-used interventions to prevent PTB in high-risk pregnant women:
cervical pessary, cervical length screening and vaginal proges-
terone. Certainly there are other interventions that are absent be-
cause they we not the subject of a Cochrane Review. For these three
specific interventions, we direct readers to several other SRs. Sac-
cone 2017a and Saccone 2017b reviewed trials of cervical pessary
for women with singleton and multiple pregnancy and short cervix;
pessary did not reduce the rate of sPTB or improve outcomes for
the neonate. Berghella 2017 found that cervical length screening
reduced women’s risk of preterm before 37 weeks' gestation, but
led to no improvements in other outcomes for women or neonates.
Romero 2018 reported that vaginal progesterone reduced risk of
preterm births < 33 weeks' gestation for women with singleton
pregnancy and a short cervix mid-trimester; progesterone also im-
proved outcomes for the neonate. We also look forward to the EPP-
PIC collaboration’s individual participant data (IPD) meta-analy-
sis of progestogens (Stewart 2017), and to an updated Cochrane
Review on progestogens for singleton pregnancy (Dodd and col-
leagues, forthcoming). A network meta-analysis comparing prog-
esterone, cerclage and cervical pessary was also relevant; Jarde
2017a found that progesterone (natural and 17-OHPC were both in-
cluded here) was the most effective for preventing PTB in single-
ton pregnancy. No intervention was effective to prevent PTB in twin
pregnancy (Jarde 2017b).
Quality of the evidence
We did not conduct formal evaluation of the risks of bias in included
SRs with either the AMSTAR or ROBIS tool, due to our confidence in
Cochrane Review methodology. All Cochrane Review authors must
conduct exhaustive searches for published and unpublished stud-
ies; an Information Specialist checks review search results, and ed-
itorial topic experts check review authors’ eligibility decisions. All
review authors apply Cochrane's 'Risk of bias' tool to included tri-
als and report transparent results in tables (Higgins 2011a). From
2016, all Cochrane review authors also assess the quality of review
effect estimates using GRADE criteria and report results in 'Sum-
mary of findings' tables (Higgins 2018). Cochrane Review method-
ology alerts readers to potential bias in pooled effect estimates.
Our overview further classified review effect estimates to assign a
graphic icon and communicate evidence quality (see Figure 2).
To ensure the credible interpretation of SR estimates researchers
should consider whether meta-analyses have adequate statistical
power (e.g. Schünemann 2013). GRADE criteria consider the impre-
cision of a pooled estimate, which is related to power, but no SR
included in this overview formally reported whether a meta-analy-
sis had adequate data to draw meaningful conclusions. Overview
authors may provide such context to improve interpretation of SR
evidence.
We also question how far an overview should attempt to inter-
pret SR results in terms of practice recommendations. If individual
SRs should not make clinical recommendations (see Higgins 2011b,
section 12.7.4 "Common errors in reaching conclusions"), then nei-
ther should overviews of reviews, unless overview authors have
embarked upon a formal process to vet all available evidence and
produce fully-contextualised clinical guidance.
An example of an evidence synthesis project that can endorse spe-
cific interventions for clinical practice is a SR of relevant guidelines.
Medley 2018 reviewed recommendations in 49 clinical guidelines
to identify international consensus for specific interventions to pre-
vent or manage PTB.
We draw attention to a lack of a good evidence base for women
with multiple pregnancy. We classified all evidence relevant to mul-
tiple pregnancy to be of unknown harm or benefit, and of low- or
very-low quality, with the exception of intramuscular progesterone
(which may be harmful for women, see Dodd 2017 and Figure 6). We
currently have no credible options to offer this population, and this
situation must change. Clinicians, researchers and funders must
address the lack of high-quality evidence for interventions relevant
to women at high risk of preterm birth due to multiple pregnancy.
Potential biases in the overview process
We followed standard methods to minimise bias. Two overview au-
thors independently conducted eligibility assessment and data ex-
traction, with resolution of conflicts through consultation with a
third overview author. None of the overview authors appraised his
or her own SR for inclusion; likewise, overview authors did not as-
sess outcome data or assign graphic icons to pooled effect esti-
mates from their own SRs.
We changed our methods from those presented in our protocol to
accommodate the large number of included SRs and to communi-
cate the evidence we found. Such deviation from protocol may be
considered a source of bias.
Agreements and disagreements with other studies or
reviews
We found three other publications that assessed SRs relevant to
PTB prevention. We found no study that summarised randomised
trial evidence for interventions according to a classification scheme
similar to ours.
Piso 2014 summarised 56 Cochrane Reviews of interventions to
reduce PTB at less than 37 weeks' gestation. Authors found
three interventions that increased preterm birth: metronidazole
for pregnant women with asymptomatic trichomoniasis (Gülme-
zoglu 2011); oestrogen supplementation to prevent miscarriage;
and vitamin C (Bamigboye 2003). The metronidazole and oestro-
gen Cochrane Reviews are out of date and are not included in this
overview. The result for vitamin C in an updated review included
here no longer shows harm but rather shows equivalence of vita-
min C with the comparator (Rumbold 2015a, see also Figure 7). Piso
cites 12 additional reviews reporting benefit to women, including
interventions such as smoking cessation programs and antenatal
genital tract infection screening. Our overview does not included
the same set of Cochrane Reviews as Piso because some of these
Cochrane Reviews are now out-of-date.
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Nijman 2016 reviewed interventions to diagnose and treat threat-
ened PTB. The authors found that cervical length measurement
combined with fetal fibronectin was the most effective way to iden-
tify women who may labour within seven days; corticosteroids
improved neonatal outcome; tocolytic therapy should be restrict-
ed to 48 hours’ use; maintenance tocolysis did not work; mag-
nesium sulphate improved neurological outcomes for the baby;
and erythromycin improved neonatal outcomes when women had
preterm prelabour rupture of membranes.
Lucaroni 2018 summarised SRs of biomarkers to predict sponta-
neous PTB and concluded that cervical fetal fibronectin, alpha fe-
toprotein, C-reactive protein and interleukin 6 each had good diag-
nostic accuracy to identify women at risk of spontaneous PTB.
One of the important challenges we faced was the appropriate use
of user-friendly language bearing in mind that a significant pro-
portion of the readership may not have English as their first lan-
guage. Jones 2012 categorised interventions for pain during labour
with “What works”; “What may work”; and “Insufficient evidence.”
For Ciapponi 2017, an “effective” intervention had GRADE moder-
ate- or high-certainty evidence showing benefit for a key outcome
and no negative effects via other outcomes; similarly, for Shep-
herd 2017, “effective” meant GRADE high-quality evidence. Far-
quhar 2018 classified interventions as effective, promising, ineffec-
tive, and possibly ineffective or no conclusions, possible due to lack
of evidence.
We aimed to create a similarly straight-forward classification
scheme able to communicate both review conclusions about an
interventions and GRADE criteria and decision-making. We also
wanted readers to be able to consider multiple reviews together
in the same figure, without encouraging the direct comparison of
relative risk estimates across different SRs. To this end, we creat-
ed the graphic icons to communicate the effects of interventions
and our confidence in the estimates. To improve the usefulness of
overviews, researchers should agree standard language and inves-
tigate new ways to communicate complex SR evidence via graphic
or interactive media.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
No clear evidence of harm from any of the included intervention is
reassuring, but the possibility that as many as four may be harm-
ful to women and neonates is a concern. For anyone contemplating
their implementation, a careful risk/benefit assessment should be
made depending on the setting and available alternative. Reduced
antenatal visits may have increased women’s risk of perinatal death
in settings where pregnant women already received limited ante-
natal care (Dowswell 2015). Likewise, women’s risk of preterm birth
(PTB) may have increased with the administration of: intramuscu-
lar progesterone for women with multiple pregnancy (Dodd 2017);
vitamin D, calcium and other supplements for women without pre-
existing conditions (De-Regil 2016); and external cephalic version
for women with breech presentation before term (Hutton 2015).
For health systems where the four effective interventions listed in
the discussion are not part of clinical care, a rationale for their ex-
clusion should be made available to users. The forums in which
such decisions can be justified may not exist, but this can hardly
be an excuse today when access to some form of social media is
almost universal. The overview summarises no evidence for cervi-
cal pessary, cervical length assessment and vaginal progesterone
in singleton pregnancy because these Cochrane Reviews were not
current. Readers should be aware that these are active areas for
PTB research.
The graphic icons assigned to systematic review effect estimates
do not constitute clinical guidance or an endorsement of specif-
ic interventions for pregnant women. Readers should refer to full
systematic reviews for important details on clinical efficacy, tar-
get populations, and the geographic setting of clinical trials. Preg-
nant women and their healthcare providers must carefully consid-
er whether specific strategies to prevent PTB will be of benefit for
individual women, or for specific populations of women.
Implications for research
The difficulty of maintaining timeliness of live systematic reviews in
such an active research field as PTB prevention cannot be overstat-
ed. Researchers associated with Cochrane have proposed strate-
gies to streamline review production in a series of papers (Elliott
2017). Limiting meta-analyses to priority outcome domains and
measures may also make regular updates more feasible and facili-
tate easier and more accurate data pooling (van't HooR 2016). Fu-
ture updates of Cochrane Reviews should apply the Global Alliance
to Prevent Prematurity and Stillbirth (GAPPS) classification system
or another to enable more nuanced reporting and analysis of PTB
(Villar 2012).
Formal consensus work is needed to establish standardised lan-
guage for overviews and to draw limits for their interpretation of
review evidence and its (un)certainty for benefit or harm.
For effective interventions, the underlying mechanism of action on
PTB or perinatal death was not always clear. Whilst this should not
be an excuse for not implementing interventions demonstrating
clear benefit, researchers must be encouraged to find the links that
would enable further improvements and open other areas of scien-
tific enquiry.
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ipants
(women)
Alfirevic 2015
Fetal and umbilical
Doppler ultrasound
in normal pregnan-
cy.
28 Febru-
ary 2015
5 14,185 1. Perina-
tal
death
with
anom-
alies
2. Any
death
after
ran-
domi-
sation
3. Neona-
tal
death
(to 28
days)
4. Still-
birth
5. Poten-
tially
pre-
ventable
perina-
tal
death
6. Preterm
birth <
37
weeks
7. Gesta-
tional
age at
birth
Existing evidence does not provide conclusive evidence
that the use of routine umbilical artery Doppler ultra-
sound, or combination of umbilical and uterine artery
Doppler ultrasound in low-risk or unselected popula-
tions benefits either mother or baby. Future studies
should be designed to address small changes in peri-
natal outcome, and should focus on potentially pre-
ventable deaths.
Alfirevic 2017a
Cervical stitch (cer-
clage) for prevent-
ing preterm birth in
singleton pregnan-
cy.
30 June
2016
15 3490 1. Perina-
tal
death
2. Still-
birth
3. Neona-
tal
death
4. Preterm
birth <
37, <
34 and
< 28
weeks
Cervical cerclage reduces the risk of preterm birth in
women at high risk of preterm birth and probably re-
duces risk of perinatal deaths. There was no evidence
of any differential effect of cerclage based on previ-
ous obstetric history or short cervix indications, but da-
ta were limited for all clinical groups. The question of
whether cerclage is more or less effective than other
preventative treatments, particularly vaginal proges-
terone, remains unanswered.
Alfirevic 2017b
Fetal and umbilical
Doppler ultrasound
in high-risk preg-
nancies
31 March
2017
19 10,667 1. Perina-
tal
death
2. Preterm
labour
Current evidence suggests that the use of Doppler ul-
trasound on the umbilical artery in high-risk pregnan-
cies reduces the risk of perinatal deaths and may result
in fewer obstetric interventions. The results should be
interpreted with caution, as the evidence is not of high
quality. Serial monitoring of Doppler changes in duc-
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< 37
weeks
tus venosus may be beneficial, but more studies of high
quality with follow-up including neurological develop-
ment are needed for evidence to be conclusive.
Bain 2014
Interventions for
managing asthma
in pregnancy.
2 June
2014
8 1181 1. Perina-
tal
death
2. Still-
birth
3. Neona-
tal
death
4. Preterm
birth
5. Gesta-
tional
age at
birth
Based on eight included trials, of moderate quality
overall, no firm conclusions about optimal interven-
tions for managing asthma in pregnancy can be made.
Five trials assessing pharmacological interventions did
not provide clear evidence of benefits or harms to sup-
port or refute current practice.
Bain 2015
Diet and exercise
interventions for
preventing gesta-
tional diabetes mel-
litus.
This review was up-
dated as
11 Febru-
ary 2014
13 4983 1. Perina-
tal
death
2. Still-
birth
3. Neona-
tal
death
4. Preterm
birth
5. Gesta-
tional
age at
birth
Based on the data currently available, conclusive evi-
dence is not available to guide practice.
Boelig 2016
Interventions for
treating hypereme-
sis gravidarum.
20 Decem-
ber 2015
25 2052
across 18
compar-
isons
1. Still-
birth
and
neona-
tal
death
2. Preterm
birth
On the basis of this review, there is little high-quality
and consistent evidence supporting any one interven-
tion, which should be taken into account when making
management decisions.
Bricker 2015a
Routine ultrasound
in late pregnancy
(after 24 weeks'
gestation).
31 May
2015
13 34,980 1. Perina-
tal
death
2. Still-
birth
3. Neona-
tal
death
4. Preterm
birth
5. Gesta-
tional
age at
birth
Based on existing evidence, routine late pregnancy ul-
trasound in low-risk or unselected populations does
not confer benefit on mother or baby. There was no dif-
ference in the primary outcomes of perinatal mortal-
ity, preterm birth less than 37 weeks, caesarean sec-
tion rates, and induction of labour rates if ultrasound in
late pregnancy was performed routinely versus not per-
formed routinely.
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Bricker 2015b
Nutritional advice
for improving out-
comes in multiple
pregnancies.
15 June
2015
0 0 None There is no robust evidence from randomised trials to
indicate whether specialised diets or nutritional advice
for women with multiple pregnancies do more good
than harm. There is a clear need to undertake a ran-
domised controlled trial.
Brown 2016
Dietary supplemen-
tation with myo-
inositol in women
during pregnancy
for treating gesta-
tional diabetes.
7 April
2016
2 142 1. Preterm
birth
There are insufficient data to evaluate the effect of
myo-inositol for the treatment of gestational diabetes,
with no data to examine the majority of outcomes in
this review. There do not appear to be any benefits for
the infant associated with exposure to myo-inositol
Brown 2017a
Lifestyle interven-
tions for the treat-
ment of women
with gestational di-
abetes.
14 May
2016
15 4501 1. Perina-
tal
death
2. Preterm
birth <
37 and
< 32
weeks
Lifestyle interventions are the primary therapeu-
tic strategy for women with GDM. Women receiving
lifestyle interventions were less likely to have postna-
tal depression and were more likely to achieve postpar-
tum weight goals. Exposure to lifestyle interventions
was associated with a decreased risk of the baby being
born LGA and decreased neonatal adiposity. Long-term
maternal and childhood/adulthood outcomes were
poorly reported. The value of lifestyle interventions in
low- and middle-income countries or for different eth-
nicities remains unclear. The longer-term benefits or
harms of lifestyle interventions remains unclear due to
limited reporting.
Brown 2017b
Exercise for preg-
nant women with
gestational dia-
betes for improving
maternal and fetal
outcomes.
27 August
2016
11 638 1. Perina-
tal
death
2. Preterm
birth <
37 and
< 32
weeks
Short- and long-term outcomes of interest for this re-
view were poorly reported. Current evidence is con-
founded by the large variety of exercise interventions.
There was insufficient high-quality evidence to be able
to determine any differences between exercise and
control groups for our outcomes of interest.
Brown 2017c
Oral anti-diabet-
ic pharmacolog-
ical therapies for
the treatment of
women with gesta-
tional diabetes.
14 May
2016
11 1487 None There were insufficient data comparing oral anti-dia-
betic pharmacological therapies with placebo/stan-
dard care (lifestyle advice) to inform clinical practice.
There was insufficient high-quality evidence to be able
to draw any meaningful conclusions as to the benefits
of one oral anti-diabetic pharmacological therapy over
another due to limited reporting of data for the prima-
ry and secondary outcomes in this review. Short- and
long-term clinical outcomes for this review were inade-
quately reported or not reported. Current choice of oral
anti-diabetic pharmacological therapy appears to be
based on clinical preference, availability and national
clinical practice guidelines.
Buppasiri 2015
Calcium supple-
mentation (other
than for preventing
or treating hyper-
tension) for improv-
30th
Septem-
ber 2014
25 18587 1. Perina-
tal
death
2. Still-
birth or
This review indicates that there are no clear additional
benefits to calcium supplementation in prevention of
preterm birth or low infant birthweight.
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ing pregnancy and
infant outcomes.
fetal
death
3. Preterm
birth
Carberry 2014
Customised versus
population-based
growth charts as a
screening tool for
detecting small for
gestational age in-
fants in low-risk
pregnant women.
12 March
2014
0 0 None There is no randomised trial evidence currently avail-
able. Further randomised trials are required to accu-
rately assess whether the improvement in detection
shown is secondary to customised charts alone or an
effect of the policy change.
Catling 2015
Group versus con-
ventional antenatal
care for women.
31 Octo-
ber 2014
4 2350 1. Perina-
tal
death
2. Preterm
birth
3. Gesta-
tional
age at
birth
Available evidence suggests that group antenatal care
is acceptable to women and is associated with no ad-
verse outcomes for them or for their babies. No differ-
ences in the rate of preterm birth were reported when
women received group antenatal care. This review is
limited because of the small numbers of studies and
women, and because one study contributed 42% of
the women. Most of the analyses are based on a sin-
gle study. Additional research is required to determine
whether group antenatal care is associated with signifi-
cant benefit in terms of preterm birth or birthweight.
Chamberlain 2017
Psychosocial inter-
ventions for sup-
porting women to
stop smoking in
pregnancy.
13 No-
vember
2015
102 28,000 1. Perina-
tal
death
2. Preterm
birth <
37
weeks
Psychosocial interventions to support women to stop
smoking in pregnancy can increase the proportion of
women who stop smoking in late pregnancy and the
proportion of infants born low birthweight.
Cluver 2017
Interventions for
treating genital
Chlamydia tra-
chomatis infection
in pregnancy.
26 June
2017
15 1754 1. Perina-
tal
death
2. Preterm
birth
Treatment with antibacterial agents achieves microbi-
ological cure from C. trachomatis infection during preg-
nancy. There was no apparent difference between as-
sessed agents (amoxicillin, erythromycin, clindamycin,
azithromycin) in terms of efficacy (microbiological cure
and repeat infection) and pregnancy complications
(preterm birth, preterm rupture of membranes, low
birthweight). Azithromycin and clindamycin appear to
result in fewer side effects than erythromycin.
Coleman 2015
Pharmacological
interventions for
promoting smok-
ing cessation dur-
ing pregnancy.
11 July
2015
9 2210 1. Still-
birth
2. Neona-
tal
death
3. Preterm
birth
There is no evidence that NRT used for smoking ces-
sation in pregnancy has either positive or negative im-
pacts on birth outcomes.
da Silva Lopes 2017
Bed rest with and
without hospitali-
sation in multiple
pregnancy for im-
30 May
2016
6 636 1. Preterm
birth
The evidence to date is insufficient to inform a policy of
routine bed rest in hospital or at home for women with
a multiple pregnancy.
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proving perinatal
outcomes.
Davey 2015
Risk-scoring sys-
tems for predicting
preterm birth with
the aim of reducing
associated adverse
outcomes.
30 June
2015
0 0 None The role of risk-scoring systems in the prevention of
preterm birth is unknown.
De-Regil 2015
Effects and safety
of periconception-
al oral folate sup-
plementation for
preventing birth de-
fects.
31 August
2015
5 7391 1. Still-
birth
2. Neona-
tal
death
3. Preterm
birth
Folic acid, alone or in combination with vitamins and
minerals, prevents neural tube defects, but does not
have a clear effect on other birth defects.
De-Regil 2016
Vitamin D sup-
plementation for
women during
pregnancy.
23 Febru-
ary 2015
15 2388 1. Still-
birth
2. Neona-
tal
death
3. Preterm
birth
New studies have provided more evidence on the ef-
fects of supplementing pregnant women with vitamin
D alone or with calcium on pregnancy outcomes. Sup-
plementing pregnant women with vitamin D in a single
or continued dose increases serum 25-hydroxyvitamin
D at term and may reduce the risk of pre-eclampsia,
low birthweight and preterm birth. However, when vit-
amin D and calcium are combined, the risk of preterm
birth is increased. The clinical significance of the in-
creased serum 25-hydroxyvitamin D concentrations is
still unclear. In light of this, these results need to be in-
terpreted with caution. Data on adverse effects were
lacking in all studies.
Dodd 2015a
Reduction of the
number of fetuses
for women with a
multiple pregnan-
cy.
31 July
2015
0 0 None We found no available data from randomised trials
to inform the risks and benefits of pregnancy reduc-
tion procedures for women with a multiple pregnan-
cy. While randomised controlled trials will provide the
most reliable evidence about the risks and benefits of
fetal reduction procedures, reduction in the number of
fetuses by selective termination may not be acceptable
to women, particularly couples with a past history of
infertility. The acceptability of this option, and willing-
ness to undergo randomisation will depend on the cou-
ple's social background and beliefs, and consequently,
recruitment to such a trial may prove exceptionally dif-
ficult.
Dodd 2015b
Specialised ante-
natal clinics for
women with a mul-
tiple pregnancy for
improving mater-
nal and infant out-
comes.
31 May
2015
1 162 1. Perina-
tal
death
2. Still-
birth
3. Neona-
tal
death
There is currently limited information available from
randomised controlled trials to assess the role of 'spe-
cialised' antenatal clinics for women with a multiple
pregnancy compared with 'standard' antenatal care in
improving maternal and infant health outcomes.
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Dodd 2017
Prenatal adminis-
tration of progesto-
gens for prevent-
ing spontaneous
preterm birth in
women with a mul-
tiple pregnancy.
1 Novem-
ber 2016
17 4773 1. Perina-
tal
death
2. Preterm
birth <
37, <
34 and
< 28
weeks
Overall, for women with a multiple pregnancy, treat-
ment with progesterone (either intramuscular or
vaginal) does not appear to reduce the likelihood of
preterm birth or improve outcomes for babies.
Dowswell 2015
Alternative versus
standard packages
of antenatal care
for low-risk preg-
nancy.
23 March
2015
7 60,000+ 1. Perina-
tal
death
2. Preterm
birth
In settings with limited resources where the number
of visits is already low, reduced visits programmes of
antenatal care are associated with an increase in peri-
natal mortality compared to standard care, although
admission to neonatal intensive care may be reduced.
Women prefer the standard visits schedule. Where the
standard number of visits is low, visits should not be re-
duced without close monitoring of fetal and neonatal
outcome.
Farrar 2016
Continuous subcu-
taneous insulin in-
fusion versus multi-
ple daily injections
of insulin for preg-
nant women with
diabetes.
31 March
2016
5 153 1. Perina-
tal
death
2. Gesta-
tional
age at
birth
3. Preterm
birth
There is no evidence to support the use of one partic-
ular form of insulin administration over another for
pregnant women with diabetes. There are only a small
number of trials appropriate for meta-analysis, a small
number of women included and questionable general-
isability of the trial population.
Farrar 2017
Different strategies
for diagnosing ges-
tational diabetes to
improve maternal
and infant health.
9 January
2017
7 1420 1. Gesta-
tional
age at
birth
There is insufficient evidence to suggest which strategy
is best for diagnosing GDM.
Gomi 2015
Routine blood
cultures in the
management of
pyelonephritis in
pregnancy for im-
proving outcomes.
31 Decem-
ber 2014
0 0 None There are no large-scale randomised controlled trials to
assess outcomes in the management of pyelonephritis
in pregnancy with or without blood cultures.
Grivell 2015
Antenatal car-
diotocography for
fetal assessment.
26 June
2015
6 2105 1. Perina-
tal
death
2. Any po-
tential-
ly pre-
ventable
perina-
tal
death
There is no clear evidence that antenatal CTG improves
perinatal outcome, but further studies focusing on the
use of computerised CTG in specific populations of
women with increased risk of complications are war-
ranted.
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3. GA at
birth
Haider 2017
Multiple-micronu-
trient supplementa-
tion for women dur-
ing pregnancy.
11 March
2015
19 138,538 1. Perina-
tal
death
2. Preterm
birth
Our findings support the effect of MMN supplements
with iron and folic acid in improving some birth out-
comes. Overall, pregnant women who received MMN
supplementation had fewer low birthweight babies
and small-for-gestational-age babies. The findings,
consistently observed in several systematic evaluations
of evidence, provide a basis to guide the replacement
of iron and folic acid with MMN supplements contain-
ing iron and folic acid for pregnant women in low and
middle-income countries where MMN deficiencies are
common among women of reproductive age. Efforts
could focus on the integration of this intervention in
maternal nutrition and antenatal care programs in low-
and middle-income countries.
Han 2017
Different types of
dietary advice for
women with gesta-
tional diabetes.
8 March
2016
19 1398 1. Perina-
tal
death
2. Preterm
birth
Evidence from 19 trials assessing different types of di-
etary advice for women with GDM suggests no clear
differences for primary outcomes and secondary out-
comes assessed using GRADE, except for a possible re-
duction in caesarean section for women receiving a
DASH diet compared with a control diet. Few differ-
ences were observed for secondary outcomes.
Harding 2017
Iodine supplemen-
tation for women
during the precon-
ception, pregnancy
and postpartum pe-
riod
14 No-
vember
2016
11 2700 1. Perina-
tal
death
2. Preterm
birth
There were insufficient data to reach any meaningful
conclusions on the benefits and harms of routine io-
dine supplementation in women before, during or after
pregnancy.
Heazell 2015
Use of biochemi-
cal tests of placen-
tal function for im-
proving pregnancy
outcome.
31 July
2015
3 740 1. Perina-
tal
death
(still-
birth or
neona-
tal
death
togeth-
er)
2. Still-
birth
3. Neona-
tal
death
4. Preterm
birth
There is insufficient evidence to support the use of bio-
chemical tests of placental function to reduce perina-
tal mortality or increase identification of small-for-ges-
tational-age infants. However, we were only able to in-
clude data from two studies that measured oestrogens
and hPL. The quality of the evidence was low or very
low.
Hofmeyr 2016
Amnioinfusion for
chorioamnionitis.
6 July
2016
1 34 None There is insufficient evidence to fully evaluate the ef-
fectiveness of using transcervical amnioinfusion for
chorioamnionitis and to assess the safety of this inter-
vention or women’s satisfaction. We did not identify
any trials that used transabdominal amnioinfusion.
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Hofmeyr 2017
Calcium supple-
mentation com-
mencing before or
early in pregnancy,
or food fortification
with calcium, for
preventing hyper-
tensive disorders of
pregnancy.
10 August
2017
1 60 1. Perina-
tal
death
2. Preterm
birth
Calcium supplementation (≥ 1 g/day) is associated with
a significant reduction in the risk of pre-eclampsia, par-
ticularly for women with low-calcium diets. The treat-
ment effect may be overestimated due to small-study
effects or publication bias. It also reduces preterm birth
and the occurrence of the composite outcome 'mater-
nal death or serious morbidity'. We considered these
benefits to outweigh the increased risk of HELLP syn-
drome, which was small in absolute numbers. The
World Health Organization recommends calcium 1.5 g
to 2 g daily for pregnant women with low dietary calci-
um intake.
Hutton 2015
External cephalic
version for breech
presentation before
term.
31 March
2015
5 2187 1. Perina-
tal
death
2. Still-
birth
3. Preterm
labour
4. Still-
birth or
neona-
tal
death <
7 days
Compared with no ECV attempt, ECV commenced be-
fore term reduces non-cephalic presentation at birth.
Compared with ECV at term, beginning ECV at between
34 to 35 weeks may have some benefit in terms of de-
creasing the rate of non-cephalic presentation, and
risk of vaginal breech birth. However, early ECV may in-
crease risk of late preterm birth, and it is important that
any future research reports infant morbidity outcomes.
Results of the review suggest that there is a need for
careful discussion with women about the timing of the
ECV procedure so that they can make informed deci-
sions.
Iheozor-Ejiofor
2017
Treating periodon-
tal disease for pre-
venting adverse
birth outcomes in
pregnant women
7 October
2016
15 7161 1. Perina-
tal
death
2. Preterm
birth <
37
weeks
It is not clear if periodontal treatment during pregnan-
cy has an impact on preterm birth (low-quality evi-
dence). There is low-quality evidence that periodontal
treatment may reduce low birth weight (< 2500 g), how-
ever, our confidence in the effect estimate is limited
Jahanfar 2014
Interventions for
preventing or re-
ducing domestic
violence against
pregnant women.
31 July
2014
10 3417 1. Preterm
birth
There is insufficient evidence to assess the effective-
ness of interventions for domestic violence on preg-
nancy outcomes. There is a need for high-quality, RCTs
with adequate statistical power to determine whether
intervention programs prevent or reduce domestic vi-
olence episodes during pregnancy, or have any effect
on maternal and neonatal mortality and morbidity out-
comes.
Jahanfar 2015
Effects of restrict-
ed caffeine intake
by mother on fetal,
neonatal and preg-
nancy outcomes.
16 Janu-
ary 2016
1 1197 1. Preterm
birth
There is insufficient evidence to confirm or refute the
effectiveness of caffeine avoidance on birthweight or
other pregnancy outcomes. There is a need to con-
duct high-quality, double-blinded RCTs to determine
whether caffeine has any effect on pregnancy outcome.
Low 2016
Screening for geni-
tal chlamydia infec-
tion.
14 Febru-
ary 2016
6 359,078 None. No
included
RCT mea-
sured the
effects of
screen-
There is an absence of RCT evidence about the effects
of chlamydia screening in pregnancy. Future RCTs of
chlamydia screening interventions should determine
the effects of chlamydia screening in pregnancy, of re-
peated rounds of screening on the incidence of chlamy-
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ing in
pregnant
women
dia-associated PID and chlamydia reinfection in gener-
al and high-risk populations.
Martis 2016
Different intensi-
ties of glycaemic
control for women
with gestational di-
abetes mellitus.
31 Janu-
ary 2016
1 180 1. Gesta-
tional
age at
birth
There is insufficient evidence to guide clinical prac-
tice for targets for glycaemic control for women with
GDM to minimise adverse effects on maternal and fe-
tal health. Glycaemic target recommendations from
international professional organisations for maternal
glycaemic control vary widely and are reliant on con-
sensus given the lack of high-quality evidence. Further
high-quality trials are needed, and these should com-
pare different glycaemic targets for guiding treatment
of women with GDM, assess both short-term and long-
term health outcomes for women and their babies, in-
clude women's experiences and assess health services
costs. Four studies are ongoing.
Matthews 2015
Interventions for
nausea and vom-
iting in early preg-
nancy.
19 Janu-
ary 2015
41 5449 1. Spon-
ta-
neous
abor-
tion
2. Still-
birth
3. Perina-
tal
death
4. Preterm
birth
Given the high prevalence of nausea and vomiting in
early pregnancy, women and health professionals need
clear guidance about effective and safe interventions,
based on systematically reviewed evidence. There is a
lack of high-quality evidence to support any particular
intervention.
Mbuagbaw 2015
Health system and
community level in-
terventions for im-
proving antenatal
care coverage and
health outcomes.
7 June
2015
34 400,000 1. Perina-
tal
death
2. Preterm
labour
Single interventions may improve ANC coverage (at
least one visit and four or more visits) and deliveries
in health facilities. Combined interventions may im-
prove ANC coverage (at least one visit), reduce perina-
tal mortality and reduce the occurrence of low birth-
weight. The effects of the interventions are unrelated
to whether they are community or health system inter-
ventions.
McCauley 2015
Vitamin A supple-
mentation during
pregnancy for ma-
ternal and newborn
outcomes.
30 March
2015
19 310,000 1. Perina-
tal
death
2. Still-
birth
3. Neona-
tal
mortal-
ity
4. Preterm
birth
The pooled results of three large trials in Nepal, Ghana
and Bangladesh (with over 153,500 women) do not cur-
rently suggest a role for antenatal vitamin A supple-
mentation to reduce maternal or perinatal mortality.
However, the populations studied were probably differ-
ent with regard to baseline vitamin A status and there
were problems with follow-up of women. There is good
evidence that antenatal vitamin A supplementation re-
duces maternal night blindness, maternal anaemia for
women who live in areas where vitamin A deficiency is
common or who are HIV-positive. In addition, the avail-
able evidence suggests a reduction in maternal infec-
tion, but these data are not of a high quality.
Middleton 2016
Different intensities
of glycaemic con-
trol for pregnant
31 Janu-
ary 2016
3 223 1. Perina-
tal
death
2. Gesta-
tional
In a very limited body of evidence, few differences in
outcomes were seen between very tight and tight-mod-
erate glycaemic control targets in pregnant women
with pre-existing type 1 diabetes, including actual gly-
caemic control achieved. There is evidence of harm (in-
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women with pre-ex-
isting diabetes.
age at
birth
creased pre-eclampsia, caesareans and birthweights
greater than 90th centile) for 'loose' control (FBG above
7 mmol/L). Future trials comparing interventions,
rather than glycaemic control targets, may be more
feasible. Trials in pregnant women with pre-existing
type 2 diabetes are required.
Moy 2017
Techniques of mon-
itoring blood glu-
cose during preg-
nancy for women
with pre-existing di-
abetes.
30 No-
vember
2016
10 538 1. Perina-
tal
death
2. Preterm
birth
This review found no evidence that any glucose mon-
itoring technique is superior to any other technique
among pregnant women with pre-existing type 1 or
type 2 diabetes. The evidence base for the effectiveness
of monitoring techniques is weak and additional evi-
dence from large well-designed randomised trials is re-
quired to inform choices of glucose monitoring tech-
niques.
Muktabhant 2015
Diet or exercise, or
both, for preventing
excessive weight
gain in pregnancy.
5 Novem-
ber 2014
65 (49
with data)
11,444 1. Preterm
birth
High-quality evidence indicates that diet or exercise,
or both, during pregnancy can reduce the risk of exces-
sive GWG. Other benefits may include a lower risk of
caesarean delivery, macrosomia, and neonatal respi-
ratory morbidity, particularly for high-risk women re-
ceiving combined diet and exercise interventions. Ma-
ternal hypertension may also be reduced. Exercise ap-
pears to be an important part of controlling weight gain
in pregnancy and more research is needed to establish
safe guidelines. Most included studies were carried out
in developed countries and it is not clear whether these
results are widely applicable to lower-income settings.
O'Neill 2017
Different insulin
types and regi-
mens for pregnant
women with pre-ex-
isting diabetes.
17 Octo-
ber 2016
5 554 1. Preterm
birth
With limited evidence and no meta-analyses, as each
trial looked at a different comparison, no firm conclu-
sions could be made about different insulin types and
regimens in pregnant women with pre-existing type 1
or 2 diabetes. Further research is warranted to deter-
mine who has an increased risk of adverse pregnan-
cy outcome. This would include larger trials, incorpo-
rating adequate randomisation and blinding, and key
outcomes that include macrosomia, pregnancy loss,
pre-eclampsia, caesarean section, fetal anomalies, and
birth trauma.
Opray 2015
Directed precon-
ception health
programs and in-
terventions for
improving preg-
nancy outcomes
for women who
are overweight or
obese.
31 Decem-
ber 2014
0 0 None We found no randomised controlled trials that as-
sessed the effect of preconception health programs
and interventions in overweight and obese women
with the aim of improving pregnancy outcomes. Un-
til the effectiveness of preconception health programs
and interventions can be established, no practice rec-
ommendations can be made. Further research is re-
quired in this area.
Ota 2015a
Zinc supplementa-
tion for improving
pregnancy and in-
fant outcome.
31 Octo-
ber 2014
21 17,000 1. Preterm
birth
2. Still-
birth or
neona-
tal
death
The evidence for a 14% relative reduction in preterm
birth for zinc compared with placebo was primarily rep-
resented by trials involving women of low income and
this has some relevance in areas of high-perinatal mor-
tality. There was no convincing evidence that zinc sup-
plementation during pregnancy results in other use-
ful and important benefits. Since the preterm associa-
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(re-
ported
as a
single
out-
come)
3. Gesta-
tional
age at
birth
tion could well reflect poor nutrition, studies to address
ways of improving the overall nutritional status of pop-
ulations in impoverished areas, rather than focusing on
micronutrient and or zinc supplementation in isolation,
should be an urgent priority.
Ota 2015b
Antenatal dietary
education and sup-
plementation to in-
crease energy and
protein intake.
31 Janu-
ary 2015
17 9030 1. Still-
birth
2. Neona-
tal
death
3. Preterm
birth
This review provides encouraging evidence that an-
tenatal nutritional education with the aim of increas-
ing energy and protein intake in the general obstetric
population appears to be effective in reducing the risk
of preterm birth, low birthweight, increasing head cir-
cumference at birth, increasing birthweight among un-
dernourished women, and increasing protein intake.
There was no evidence of benefit or adverse effect for
any other outcome reported.
Peña-Rosas 2015a
Daily oral iron sup-
plementation dur-
ing pregnancy.
10 Janu-
ary 2015
61 (44
with data)
43,274 1. Neona-
tal
death
2. Preterm
birth
Supplementation reduces the risk of maternal anaemia
and iron deficiency in pregnancy but the positive effect
on other maternal and infant outcomes is less clear.
Implementation of iron supplementation recommen-
dations may produce heterogeneous results depend-
ing on the populations' background risk for low birth-
weight and anaemia, as well as the level of adherence
to the intervention.
Peña-Rosas 2015b
Intermittent oral
iron supplementa-
tion during preg-
nancy.
31 July
2015
27 (21
with data)
5490 1. Neona-
tal
death
2. Preterm
birth
This review is the most comprehensive summary of
the evidence assessing the benefits and harms of in-
termittent iron supplementation in pregnant women
on haematological and pregnancy outcomes. Findings
suggest that intermittent regimens produced similar
maternal and infant outcomes as daily supplementa-
tion but were associated with fewer side effects and re-
duced the risk of high levels of Hb in mid and late preg-
nancy, although the risk of mild anaemia near term was
increased. While the quality of the evidence was as-
sessed as low or very low, intermittent may be a feasi-
ble alternative to daily iron supplementation among
those pregnant women who are not anaemic and have
adequate antenatal care.
Phupong 2015
Interventions for
heartburn in preg-
nancy.
30 June
2015
9 725 None Further RCTs are needed to fully evaluate the effective-
ness of interventions for heartburn in pregnancy. Fu-
ture research should also address other medications
such as histamine 2-receptor antagonists, promotility
drugs, proton pump inhibitors, and a raR-forming al-
ginate reflux suppressant in treatment of heartburn in
pregnancy. More research is needed on acupuncture
and other complimentary therapies as treatments for
heartburn in pregnancy. Future research should also
evaluate any adverse outcomes, maternal satisfaction
with treatment and measure pregnant women's quality
of life in relation to the intervention.
Radeva-Petrova
2014
1 June
2014
17 14,481 1. Still-
birth
Routine chemoprevention to prevent malaria and its
consequences has been extensively tested in RCTs,
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Drugs for prevent-
ing malaria in preg-
nant women in en-
demic areas: any
drug regimen ver-
sus placebo or No
treatment.
2. Perina-
tal
death
3. Neona-
tal and
Infant
death
4. Preterm
birth
with clinically important benefits on anaemia and para-
sitaemia in the mother, and on birthweight in infants.
Rafael 2014
Cervical stitch (cer-
clage) for prevent-
ing preterm birth in
multiple pregnan-
cy.
30 June
2014
5 1577 1. Perina-
tal
death
2. Still-
birth
3. Neona-
tal
death
4. Preterm
birth
5. Gesta-
tional
age at
birth
This review is based on limited data from five small
studies of average to above average quality. For multi-
ple gestations, there is no evidence that cerclage is an
effective intervention for preventing preterm births and
reducing perinatal deaths or neonatal morbidity.
Raman 2017
Different methods
and settings for glu-
cose monitoring
for gestational dia-
betes during preg-
nancy.
30
Septem-
ber 2016
11 1272 1. Perina-
tal
death
2. Preterm
birth
Evidence from 11 RCTs assessing different methods or
settings for glucose monitoring for GDM suggests no
clear differences for the primary outcomes or other
secondary outcomes assessed in this review.
Rumbold 2015a
Vitamin C supple-
mentation in preg-
nancy.
31 March
2015
21 22,192 1. Perina-
tal
death
2. Still-
birth
3. Neona-
tal
death
4. Preterm
birth
5. Gesta-
tional
age at
birth
The data do not support routine vitamin C supplemen-
tation alone or in combination with other supplements
for the prevention of fetal or neonatal death, poor fe-
tal growth, preterm birth or pre-eclampsia. Further re-
search is required to elucidate the possible role of vi-
tamin C in the prevention of placental abruption and
prelabour rupture of membranes. There was no con-
vincing evidence that vitamin C supplementation alone
or in combination with other supplements results in
other important benefits or harms.
Rumbold 2015b
Vitamin E supple-
mentation in preg-
nancy.
31 March
2015
29 24,300 1. Still-
birth
2. Neona-
tal
death
3. Perina-
tal
death
The data do not support routine vitamin E supplemen-
tation in combination with other supplements for the
prevention of stillbirth, neonatal death, preterm birth,
pre-eclampsia, preterm or term PROM or poor fetal
growth. Further research is required to elucidate the
possible role of vitamin E in the prevention of placental
abruption. There was no convincing evidence that vita-
min E supplementation in combination with other sup-
plements results in other important benefits or harms.
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4. Preterm
birth
5. Gesta-
tional
age at
birth
Salam 2015a
Effect of admin-
istration of anti-
helminthics for
soil-transmitted
helminths during
pregnancy.
31 Janu-
ary 2015
4 4265 1. Perina-
tal
death
2. Preterm
birth
The evidence to date is insufficient to recommend use
of antihelminthic for pregnant women after the first
trimester of pregnancy. More well-designed, large-scale
randomised controlled trials are needed to establish
the benefit of antihelminthic treatment during preg-
nancy.
Salam 2015b
Impact of
Haemophilus in-
fluenzae type B
(Hib) and viral in-
fluenza vaccina-
tions in pregnan-
cy for improving
maternal, neonatal
and infant health
outcomes.
29 Janu-
ary 2015
2 2262 1. Perina-
tal
death
2. Infant
death
3. Preterm
birth
There is limited evidence (from one small trial at a high
risk of bias) on the effectiveness on Hib during preg-
nancy for improving maternal, neonatal and infant
health outcomes. Evidence from one large high-qual-
ity trial on the effectiveness of viral influenza vaccine
during pregnancy suggests reduced RT-PCR confirmed
influenza among women and their babies, suggesting
the potential of this strategy for scale up but further ev-
idence from varying contexts is required. Further trials
for both Hib and viral influenza vaccines with appropri-
ate study designs and suitable comparison groups are
required.
Salam 2015c
Pyridoxine (vitamin
B6) supplementa-
tion during preg-
nancy or labour
for maternal and
neonatal outcomes.
31 March
2015
4 1646 None There were few trials, reporting few clinical outcomes
and mostly with unclear trial methodology and inade-
quate follow-up. There is not enough evidence to de-
tect clinical benefits of vitamin B6 supplementation
in pregnancy and/or labour other than one trial sug-
gesting protection against dental decay. Future trials
assessing this and other outcomes such as orofacial
cleRs, cardiovascular malformations, neurological de-
velopment, preterm birth, pre-eclampsia and adverse
events are required.
Sandall 2016
Midwife-led conti-
nuity models ver-
sus other models of
care for childbear-
ing women.
31 May
2015
15 17,674 1. Overall
fetal
loss
and
neona-
tal
death
2. Preterm
birth
This review suggests that women who received mid-
wife-led continuity models of care were less likely to
experience intervention and more likely to be satisfied
with their care with at least comparable adverse out-
comes for women or their infants than women who re-
ceived other models of care.
Further research is needed to explore findings of few-
er preterm births and fewer fetal deaths less than 24
weeks, and all fetal loss/neonatal death associated
with midwife-led continuity models of care.
Sangkomkamhang
2015
Antenatal lower
genital tract in-
fection screening
and treatment pro-
grams for prevent-
30 No-
vember
2014
1 4155 1. Neona-
tal
death
2. Preterm
birth
There is evidence from one trial that infection screen-
ing and treatment programs for pregnant women be-
fore 20 weeks' gestation reduce preterm birth and
preterm low birthweight. Infection screening and treat-
ment programs are associated with cost savings when
used for the prevention of preterm birth. Future trials
should evaluate the effects of different types of infec-
tion screening programs.
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ing preterm deliv-
ery.
Schneeberger 2015
Interventions for
preventing recur-
rent urinary tract
infection during
pregnancy.
20 May
2015
1 200 1. Miscar-
riage
2. Preterm
birth
A daily dose of nitrofurantoin and close surveillance
has not been shown to prevent RUTI compared with
close surveillance alone. A significant reduction of ASB
was found in women with a high clinic attendance rate
and who received nitrofurantoin and close surveil-
lance. There was limited reporting of both primary and
secondary outcomes for both women and infants. No
conclusions can be drawn regarding the optimal inter-
vention to prevent RUTI in women who are pregnant.
Randomised controlled trials comparing different phar-
macological and non-pharmacological interventions
are necessary to investigate potentially effective inter-
ventions to prevent RUTI in women who are pregnant.
Smaill 2015
Antibiotics for
asymptomatic bac-
teriuria in pregnan-
cy.
19 March
2015
14 2000 1. Preterm
birth
While antibiotic treatment is effective in reducing the
risk of pyelonephritis in pregnancy, the estimate of the
effect is very uncertain because of the very low qual-
ity of the evidence. The reduction in low birthweight
and preterm birth with antibiotic treatment is consis-
tent with theories about the role of infection in adverse
pregnancy outcomes, but this association should be in-
terpreted with caution given the very poor quality of
the included studies.
Smyth 2015
Interventions for
varicose veins and
leg oedema in preg-
nancy.
31 May
2015
7 326 None There is moderate-quality evidence to suggest that ru-
tosides appear to help relieve the symptoms of vari-
cose veins in late pregnancy. However, this finding
is based on one study (69 women) and there are not
enough data presented in the study to assess its safety
in pregnancy. Reflexology or water immersion appears
to help improve symptoms for women with leg oede-
ma, but again this is based on two small studies (43 and
32 women, respectively).
Sosa 2015
Bed rest in single-
ton pregnancies for
preventing preterm
birth.
18 Decem-
ber 2014
2 1266 1. Preterm
birth
There is no evidence, either supporting or refuting
the use of bed rest at home or in hospital, to prevent
preterm birth. Although bed rest in hospital or at home
is widely used as the first step of treatment, there is no
evidence that this practice could be beneficial. Due to
the potential adverse effects that bed rest could have
on women and their families, and the increased costs
for the healthcare system, clinicians should discuss the
pros and cons of bed rest to prevent preterm birth. Po-
tential benefits and harms should be discussed with
women facing an increased risk of preterm birth. Ap-
propriate research is mandatory. Future trials should
evaluate both the effectiveness of bed rest, and the ef-
fectiveness of the prescription of bed rest, to prevent
preterm birth.
Spencer 2015
Screening and sub-
sequent manage-
ment for thyroid
dysfunction pre-
pregnancy and dur-
14 July
2015
2 26,408 1. Fetal
and
neona-
tal
death
(re-
ported
Based on the existing evidence, though universal
screening for thyroid dysfunction in pregnancy increas-
es the number of women diagnosed with hypothy-
roidism who can be subsequently treated, it does not
clearly impact (benefit or harm) maternal and infant
outcomes. More evidence is needed to assess the bene-
fits or harms of different screening methods for thyroid
Table 1.   Characteristics of included systematic reviews  (Continued)
Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
54
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
ing pregnancy for
improving maternal
and infant health.
as a
single
out-
come)
2. Miscar-
riage
3. Preterm
birth
4. Preterm
labour
dysfunction in pregnancy, on maternal, infant and child
health outcomes. Future trials should assess impacts
on use of health services and costs, and be adequate-
ly powered to evaluate the effects on short- and long-
term outcomes.
Suchdev 2015
Multiple micronu-
trient powders for
home (point-of-
use) fortification of
foods in pregnant
women.
31 Janu-
ary 2015
2 1172 None Limited evidence suggests that micronutrient powders
for point-of-use fortification of foods have no clear dif-
ference as multiple micronutrient supplements on ma-
ternal anaemia (very low-quality evidence) and Hb at
or near term. There is limited evidence to suggest that
women were more likely to adhere to taking tablets
than using micronutrient powders.
Terplan 2015
Psychosocial inter-
ventions for preg-
nant women in
outpatient illicit
drug treatment pro-
grams compared to
other interventions.
January
2015
14 1298 1. Preterm
birth
The present evidence suggests that there is no differ-
ence in treatment outcomes to address drug use in
pregnant women with use of psychosocial interven-
tions, when taken in the presence of other comprehen-
sive care options. However, few studies evaluated ob-
stetrical or neonatal outcomes and rarely did so in a
systematic way, making it difficult to assess the effect
of psychosocial interventions on these clinically im-
portant outcomes. It is important to develop a better
evidence base to evaluate psychosocial modalities of
treatment in this important population.
Thinkhamrop 2015
Antibiotic prophy-
laxis during the
second and third
trimester to reduce
adverse pregnancy
outcomes and mor-
bidity.
31 July
2014
7 2100 1. Perina-
tal
death
2. Preterm
birth
3. Gesta-
tional
age at
birth
Antibiotic prophylaxis did not reduce the risk of
preterm prelabour rupture of membranes or preterm
delivery (apart from in the subgroup of women with a
previous preterm birth who had bacterial vaginosis).
Antibiotic prophylaxis given during the second or third
trimester of pregnancy reduced the risk of postpartum
endometritis, term pregnancy with prelabour rupture
of membranes and gonococcal infection when given
routinely to all pregnant women. Substantial bias pos-
sibly exists in the review's results because of a high rate
of loss to follow-up and the small numbers of studies
included in each of our analyses. There is also insuffi-
cient evidence on possible harmful effects on the ba-
by. Therefore, we conclude that there is not enough
evidence to support the use of routine antibiotics dur-
ing pregnancy to prevent infectious adverse effects on
pregnancy outcomes.
Tieu 2017a
Interconception
care for women
with a history of
gestational dia-
betes for improving
maternal and infant
outcomes.
7 April
2017
0 0 None The role of interconception care for women with a his-
tory of GDM remains unclear. Randomised controlled
trials are required evaluating different forms and pro-
tocols of interconception care for these women on peri-
natal and long-term maternal and infant health out-
comes, acceptability of such interventions and cost-ef-
fectiveness.
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Tieu 2017b
Dietary advice in-
terventions in preg-
nancy for prevent-
ing gestational dia-
betes.
3 January
2016
11 2786 1. Perina-
tal
death
2. Gesta-
tional
age at
birth
Very low-quality evidence from five trials suggests a
possible reduction in GDM risk for women receiving
dietary advice versus standard care, and low-quality
evidence from four trials suggests no clear difference
for women receiving low- versus moderate- to high-GI
dietary advice. A possible reduction in pregnancy-in-
duced hypertension for women receiving dietary ad-
vice was observed and no clear differences were seen
for other reported primary outcomes. There were few
outcome data for secondary outcomes. More high-
quality evidence is needed to determine the effects of
dietary advice interventions in pregnancy.
Tieu 2017c
Oral anti-diabetic
agents for women
with established di-
abetes/impaired
glucose tolerance
or previous ges-
tational diabetes
planning pregnan-
cy, or pregnant
women with pre-ex-
isting diabetes .
31 Octo-
ber 2016
3 241 1. Perina-
tal
death
2. Preterm
birth <
37 and
< 32
weeks
There are insufficient RCT data to evaluate the use of
oral anti-diabetic agents in women with established
diabetes, impaired glucose tolerance or previous ges-
tational diabetes who are planning a pregnancy, or in
pregnant women with pre-existing diabetes.
Tieu 2017d
Screening for gesta-
tional diabetes mel-
litus based on dif-
ferent risk profiles
and settings for im-
proving maternal
and infant health.
31 Janu-
ary 2017
2 4523 1. Perina-
tal
death
2. Preterm
birth
Further, high-quality randomised controlled trials are
needed to assess the value of screening for GDM, which
may compare different protocols, guidelines or pro-
grammes for screening (based on different risk profiles
and settings), with the absence of screening, or with
other protocols, guidelines or programmes. There is a
need for future trials to be sufficiently powered to de-
tect important differences in short- and long-term ma-
ternal and infant outcomes, such as those important
outcomes pre-specified in this review. As only a propor-
tion of women will be diagnosed with GDM in these tri-
als, large sample sizes may be required.
Till 2015
Incentives for in-
creasing prenatal
care use by women
in order to im-
prove maternal and
neonatal outcomes.
31 Janu-
ary 2015
5 11,935 None The included studies did not report on this review's
main outcomes: preterm birth, small-for-gestational
age, or perinatal death. There is limited evidence that
incentives may increase utilisation and quality of pre-
natal care, but may also increase caesarean rate. Over-
all, there is insufficient evidence to fully evaluate the
impact of incentives on prenatal care initiation. There
is a need for high-quality RCTs to determine whether
incentive program increase prenatal care use and im-
prove maternal and neonatal outcomes. Incentive pro-
grams, in particular cash-based programs, as suggest-
ed in this review and in several observational studies
may improve the frequency and ensure adequate qual-
ity of prenatal care.
Urquhart 2017
Home uterine mon-
itoring for detecting
preterm labour.
30 June
2016
15 6008 1. Perina-
tal
death
2. Preterm
birth
Home uterine monitoring may result in fewer admis-
sions to a neonatal intensive care unit, but in more un-
scheduled antenatal visits and tocolytic treatment; the
level of evidence is generally low to moderate. Impor-
tant group differences were not evident when we un-
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dertook sensitivity analysis using only trials at low risk
of bias. There is no impact on maternal and perinatal
outcomes such as perinatal mortality or incidence of
preterm birth.
Widmer 2015
Duration of treat-
ment for asympto-
matic bacteriuria
during pregnancy.
31 August
2015
13 1622 1. Preterm
birth
A single-dose regimen of antibiotics may be less effec-
tive than a short course (four- to seven-day) regimen,
but more evidence is needed from large trials measur-
ing important outcomes, such as cure rate. Women
with asymptomatic bacteriuria in pregnancy should
be treated by the standard regimen of antibiotics un-
til more data become available testing seven-day treat-
ment compared with shorter courses of three- or five-
day regimens.
Wiysonge 2017
Vitamin A supple-
ments for reducing
mother-to-child HIV
transmission.
7 Septem-
ber 2017
5 7298 1. Preterm
birth
Antepartum or postpartum vitamin A supplementation,
or both, probably has little or no effect on mother-to-
child transmission of HIV in women living with HIV in-
fection and not on antiretroviral drugs. The interven-
tion has largely been superseded by ART which is wide-
ly available and effective in preventing vertical trans-
mission.
Yamasmit 2015
Prophylactic oral
betamimetics for
reducing preterm
birth in women
with a twin preg-
nancy.
21
Septem-
ber 2015
6 374 1. Neona-
tal
death
2. Preterm
labour
3. Preterm
birth
There is insufficient evidence to support or refute the
use of prophylactic oral betamimetics for preventing
preterm birth in women with a twin pregnancy.
Zhou 2015
Interventions for
leg cramps in preg-
nancy.
31 March
2015
6 390 None It is unclear from the evidence reviewed whether any of
the interventions (oral magnesium, oral calcium, oral
vitamin B or oral vitamin C) provide an effective treat-
ment for leg cramps. This is primarily due to outcomes
being measured and reported in different, incompa-
rable ways, and design limitations compromising the
quality of the evidence (the level of evidence was grad-
ed low or very low). This was mainly due to poor study
design and trials being too small to address the ques-
tion satisfactorily.
Table 1.   Characteristics of included systematic reviews  (Continued)
ANC: antenatal care
ART: antiretroviral therapy
ASB: asymptomatic bacteriuria
CTG: cardiotocography
DASH: Dietary Approaches to Stop Hypertension
ECV: external cephalic version
FBG: fasting blood glucose
GA: gestational age
GDM: gestational diabetes mellitus
GWG: gestational weight gain
Hb: haemoglobin
HELLP: haemolysis, elevated liver enzymes, low platelets
hpl: human placental lactogen
LGA: large-for-gestational age
MMN: multiple-micronutrient
NRT: nicotine replacement therapy
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PROM: prelabour rupture of membranes
RCT: randomised controlled trial
RT-PCR: reverse-transcriptase–polymerase-chain-reaction
RUTI: recurrent urinary tract infections
UTI: urinary tract infection
 
 
Review ID Review title Reason for exclusion
Amaya-Guio 2016 Antibiotic treatment for the sexual partners of
women with bacterial vaginosis.
The review does not report results for pregnant women; the
intervention does not target health providers.
Balogun 2016a Vitamin supplementation for preventing miscar-
riage.
Reviews targets miscarriage in early pregnancy.
Balogun 2016b Interventions for initiation of breastfeeding. Overview outcomes of preterm birth and perinatal death
are not specified as review outcomes. Review concerned
with post-pregnancy outcomes.
Chi 2015 Safety of topical corticosteroids in pregnancy. All evidence is from cohort studies
Demicheli 2015 Vaccines for women for preventing neonatal
tetanus.
The intervention targets the neonate.
Dickinson 2014 Creatine for women in pregnancy for neuropro-
tection of the fetus.
The intervention targets the neonate.
Frazer 2016 Legislative smoking bans for reducing harms
from secondhand smoke exposure, smoking
prevalence and tobacco consumption.
Evidence for the effectiveness of smoking bans to impact
preterm birth comes from non-randomised study designs.
Grivell 2014 Prenatal versus postnatal repair procedures for
spina bifida for improving infant and maternal
outcomes.
Intervention targets pregnant women with major fetal ab-
normality.
Hemmingsen 2017 Dipeptidyl-peptidase (DPP)-4 inhibitors and
glucagon-like peptide (GLP)-1 analogues for
prevention or delay of type 2 diabetes mellitus
and its associated complications in people at in-
creased risk for the development of type 2 dia-
betes mellitus.
Pregnant women are excluded from many of the trials in-
cluded in this review.
Heslop 2016 Interventions for men and women with their first
episode of genital herpes.
Data are not reported for pregnant women. Pregnancy was
an exclusion criteria for several included clinical trials. The
intervention does not target healthcare providers.
Jahanfar 2017 Ultrasound for diagnosis of birthweight discor-
dance in twin pregnancies (Protocol).
This is a DTA review and no outcome data relevant to the
overview are planned.
Karanth 2015 Desmopressin acetate (DDAVP) for preventing
and treating acute bleeds during pregnancy in
women with congenital bleeding.
Preterm birth is not a review outcome.
Khattri 2017 Adjunctive systemic antimicrobials for the non-
surgical treatment of chronic and aggressive pe-
riodontitis (Protocol).
Pregnant women are excluded from this review protocol.
Table 2.   Excluded systematic reviews 
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Li 2014 Periodontal therapy for the management of car-
diovascular disease in patients with chronic pe-
riodontitis.
Pregnant women were not eligible for this review. The in-
tervention does not target healthcare providers.
Li 2016 Chinese herbal medicines for unexplained recur-
rent miscarriage.
This review is concerned with recurrent miscarriage in early
pregnancy.
Liddle 2015 Interventions for preventing and treating low-
back and pelvic pain during pregnancy.
Preterm birth and perinatal death are not specified as re-
view outcomes.
Martineau 2016 Vitamin D for the management of asthma. This review included children and adults. There is no indi-
cation that pregnant women were included or excluded
from the review.
O'Doherty 2015 Screening women for intimate partner violence
in healthcare settings.
This review is not specific to a pregnant population and no
pregnancy outcomes are specified.
Okusanya 2016 Prophylactic versus selective blood transfusion
for sickle cell disease in pregnancy.
Preterm birth mentioned in the text; only non-randomised
data presented in the discussion.
Stock 2016 Immediate versus deferred delivery of the
preterm baby with suspected fetal compromise
for improving outcomes.
Pregnant women included in this review were expected to
deliver preterm.
Tieu 2017f Preconception care for diabetic women for im-
proving maternal and infant health.
Intervention limited to the preconception period and tar-
geted women who were not pregnant. PTB is a review out-
come.
Weston 2016 Monotherapy treatment of epilepsy in pregnan-
cy: congenital malformation outcomes in the
child.
This review is concerned with outcomes for the neonate
and child.
Whitworth 2015 Ultrasound for fetal assessment in early preg-
nancy.
This review does not cover the use of ultrasound to identify
women at risk of preterm birth; that topic is covered in an-
other review.
Wilkinson 2016 Melatonin for women in pregnancy for neuro-
protection of the fetus.
The intervention in this review targets the health of the
neonate.
Table 2.   Excluded systematic reviews  (Continued)
DTA: diagnostic test accuracy
PTB: preterm birth
 
 
A P P E N D I C E S
Appendix 1. Search strategy
Date Run: 02/11/17 15:23:15.642
#1 preterm near birth* 2798
#2 preterm near lab*r 1164
#3 preterm near delivery 1213
#4 pre-term near birth* 161
#5 pre-term near delivery 89
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#6 premature near birth* 2067
#7 pre-term near lab*r 55
#8 premature near delivery 319
#9 premature near lab*r 2029
#10 MeSH descriptor: [Premature Birth] explode all trees 582
#11 MeSH descriptor: [Obstetric Labor, Premature] explode all trees 1329
#12 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 5913
Limit to Cochrane reviews and protocols
898 Cochrane reviews or protocols
Appendix 2. Eligible but out of date systematic reviews
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2. Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pessary for preventing preterm birth. Cochrane Database of Systematic Reviews
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17. Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews
2010, Issue 10. [DOI: 1002/14651858.CD000128.pub2]
18. Duley L, Henderson-Smart DJ, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database
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19. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane
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20. Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database of System-
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21. Duley L, Matar HE, Almerie MQ, Hall DR. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.
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22. Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews
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24. Eames AJ, Grivell RM, Deussen AR, Hague W, Dodd JM. Metformin for women who are obese during pregnancy for improving maternal
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tematic Reviews 2013, Issue 11. [DOI: 1002/14651858.CD008633.pub3]
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